"Bhisma" <***@email.it> ha scritto nel messaggio news:***@4ax.com...
Al FALSIFICATORE della Verita' - Al DIFFAMATORE via Usenet - All'IGNORANTE
soggetto che posta falsita' su USENET e che si chiama:
Bhisma....regalo queste Chicche di sapere, se per caso sa leggere dovrebbe
iniziare a riflettere, ma dato il tipo non sara' certamente quello il
caso...:
Vaccinazioni per l'infanzia ed autismo: un caso accertato negli Stati Uniti
Mercoledì 9 Aprile 2008
Il Governo americano ha ora ammesso che la vaccinazione può avere arrecato
danni ad una bambina di 9 anni, ed ha annunciato che si farà carico delle
spese per la cura.
Nel 2000 Hannah aveva 19 mesi ed uno sviluppo normale, quando ricevette 5
iniezioni per la prevenzione di 9 malattie infettive.
Nel 2001 alla bambina è stato diagnosticato il disturbo autistico.
Per il fatto che il padre di Hannah era un neurologo al Johns Hopkins
Hospital, la bambina è stata sottoposta ad una serie di esami, che hanno
evidenziato un disordine a livello mitocondriale.
Due teorie sono state ipotizzate: la prima che la bambina presentava una
sottostante malattia mitocondriale e che la vaccinazione ha slatentizzato,
la seconda è che la vaccinazione ha causato questo disordine.
Il Governo ha optato per la prima ipotesi: la bambina aveva una sottostante
malattia mitocondriale che è stata aggravata dalla vaccinazione.
Molti dei vaccini che Hannah ha ricevuto contenevano Tiomersale, un
preservativo a base di Mercurio.
Negli Stati Uniti, il Tiomersale è stato rimosso dai vaccini somministrati
nell'infanzia a partire dal 2001.
Rimane aperto il dibattito sulle vaccinazioni multiple nell'infanzia. (
Xagena Medicina )
Fonte: The New York Times, 2008 - Medicina-Online.net + Autismo dai
VACCINI + Bibliografia su Autismo dai vaccini
E' in vendita il libro del dott. M. Montinari, Medico-Chirurgo della Polizia
di Stato di Firenze - Specialista in Chirurgia Pediatrica - Specialista in
Chirurgia d'Urgenza e P.S. - Iscritto Albo CTU Tribunale Civile e Penale di
Bari (n°582): ***@libero.it
Il dott. M. Montinari ha fino ad oggi in cura oltre 3.500 pazienti fra cui
oltre 1100 malati di autismo, da Vaccino.
I titoli dei suoi libri sono: : "AUTISMO, nuove terapie per migliorare e
guarire" + Educazione alla Salute, parliamo di sostanze Stupefacenti ed
alcool, ediz. Marianna.
Il primo libro contiene le sue ricerche (su circa 800 pazienti) indicano
la responsabilita' delle Vaccinazioni come causa della malattia
(Autismo).... 230 pagine di documentazione medico Scientifica qualificata.
Una traccia da seguire per medici, ricercatori e genitori che non hanno
perso la speranza di vedere guarire o stare molto meglio i loro figli
autistici...
Tutti i dati scientifici, le diete, le alternative agli antibiotici e le
terapie di supporto, fisiologiche, linguistiche, psicologico e senso motorio
con l'indirizzario di terapeuti ed associazioni a cui rivolgersi. - editore
Macroedizioni
Il Journal of American Physicians and Surgeons nel volume 9 numero 3 del
2004 ha pubblicato uno studio dettagliato e curato contenente considerazioni
sul legame tra vaccino antimorbillo-parotite-rosolia e autismo.
I due autori, ricercatori e medici, Yazbak e Goldman smontano pezzo per
pezzo lo studio danese di Madsen et al. pubblicato nel 2002 che rigettava
l'ipotesi di correlazione e pareva voler mettere una pietra sopra alla
questione.
Quello studio era diventato la bandiera dietro la quale era stata condotta
la feroce battaglia al medico Andrew Wakefield, primo a pubblicare su casi
clinici che mostravano il legame tra vaccino e autismo su Lancet.
Lo studio del J. of Ph. and Sur. ora constata e dimostra errori statistici e
di metodo che invaliderebbero l'intero studio di Madsen. Testo integrale
dello studio in: www.jpands.org/vol9no3/goldman.pdf
Bibliografia:
Abell F, Krams M, Ashburner J, Passingham R, Friston K, Frackowiak R,
Happé F, Frith C, Frith U, 'The neuroanatomy of autism: a voxel-based whole
brain analysis of structural scans', NeuroReport, June 1999, Vol. 10, No. 8,
1647-1651
Adams CR, Ziegler DK, Lin JT, 'Mercury intoxication simulating
amyotrophic lateral sclerosis', JAMA 1983; 250:642-643.
Al-Balaghi S, Möller E, Möller G, Abedi-Valugerdi M, 'Mercury induces
polyclonal B cell activation, autoantibody production and renal immune
complex deposits in young (NZB x NZW) F1 hybrids', Eur J Immunol, July 1996,
26(7):1519-1526
Alberti A, Pirrone P, Elia M, Waring RH, Romano C, 'Sulphation deficit
in "low-functioning" autistic children: a pilot study', Biol Psychiatry 1999
Aug 1; 46(3):420-424
Altman DG, Bland JM, 'Absence of evidence is not evidence of absence',
Br Med J, 1995;311:485
American Academy of Pediatrics and US Public Health Service, July 8,
1999, 'Thimerosal, a Mercury-containing Preservative Used in Some Vaccines'
American Psychiatric Association: Diagnostic and Statistical Manual of
Mental Disorders, Fourth Edition, Washington D.C., 1994
Amin-Zaki L, Majeed MA, Clarkson TW, Greenwood MR, 'Methylmercury
poisoning in Iraqi children: clinical observations over two years', British
Medical Journal 1978 March 1, 613-616
Amin-Zaki L, Majeed MA, Elhassani SB, Clarkson TW, Greenwood MR,
Doherty RA, 'Prenatal Methylmercury Poisoning', American Journal of the
Disabled Child, 1979 Feb 133:172-177
Amin-Zaki, L, Elhassani S, Majeed MA, Clarkson TW, Doherty RA,
Greenwood M, 'Intra-uterine methylmercury poisoning in Iraq', Pediatrics
1974 Nov 54:5587-595
Anuradha B, Rajeswari M, Varalakshmi P, 'Degree of peroxidative status
in neuronal tissues by different routes of inorganic mercury
administration',
Drug Chem Toxicol 1998 Feb;21(2):47-55
Applied Toxicology, 1992 Apr;12(2):79-84
ARI Newsletter, review, 'Long term follow-up: early intervention
effects lasting', 1993 7(1):1&6
Aronow R, Fleischmann L ,'Mercury Poisoning in Children', Clinical
Pediatrics, 1976 Oct, Vol.15, No.10, 936-945
Arvidsson T, Danielsson B, Forsberg P, Gillberg C, Johansson M,
Kjellgren G, ' Autism in 3-6 year old children in a suburb in Göteborg,
Sweden', Autism, November 1997, Vol. 1, No. 2, 163-173
Aschner M, Aschner JL, 'Mercury Neurotoxicity: Mechanisms of
Blood-Brain Barrier Transport', Neuroscience & Behavioral Reviews, 1990,
Vol. 14, 169-176
Aschner M, Lorscheider FL, Cowan KS, Conklin DR, Vimy MJ, Lash LH,
'Methallothionein induction in fetal rat brain and neonatal primary
astrocyte cultures by in utero', Brain Res, Dec 5; 778(1):222-232
Ashour H, Abdel-Rahman M, Khodair A., 1993 'The mechanism of methyl
mercury toxicity in isolated rat hepatocytes', Toxicology Letters 1993
Jul;69(1):87-96
Atchison WD and Hare MF, 'Mechanisms of methylmercury-induced
neurotoxicity', FASEB Journal 1994 Jun;8(9):622-629
Atchison WD, Joshi U, Thornburg JE, 'Irreversible Suppression of
Calcium Entry into Nerve Terminals by Methylmercury', The Journal of
Pharmacology and Experimental Therapeutics, 1986, Vol. 238, No. 2, 618-624
Aukrust P, et al, 'Decreased levels of total and reduced glutathione
in CD4+ lymphocytes in common variable immunodeficiency are associated with
activation of the tumor necrosis factor system: possible immunopathogenic
role of oxidative stress', Blood, 1995, 86.4.1383-1391
Aukrust P, et al, 'Persistent activation of the tumor necrosis factor
system in subgroup of patients with common variable immunodeficiency -
possible immunological and clinical consequences', Blood, 1996, 97.2.674-681
Aylward EH, Minshew NJ, Goldstein G, Honeycutt NA, Augustine AM, Yates
KO, Barta PE, Pearlson GD, 'MRI volumes of amygdala and hippocampus in
non-mentally retarded autistic adolescents and adults', Neurology 1999 Dec
10;53(9):2145-50
Bachevalier J, 'Brief Report: Medial Temporal Lobe and Autism: A
Putative Animal Model in Primates', Journal of Autism and Developmental
Disorders, 1996;26(2):217-220
Bachevalier J, 'Medial Temporal Lobe Structures: a Review of Clinical
and Experimental Findings', Neuropsychologia, 1994;32:627-648
Bagenstose LM, Salgame P, Monestier M, 'Mercury-induced autoimmunity
in the absence of IL-4', Clin Exp Immunol, Oct 1998, 114(1):9-12
Bagenstose LM, Salgame P, Monestier M, 'Murine mercury-induced
autoimmunity: a model of chemically related autoimmunity in humans', Immunol
Res, 1999, 20(1):67-78
Bailey A, Phillips W, Rutter M, 'Autism: Towards an Integration of
Clinical, Genetic, Neuro-psychological, and Neurobiological Perspectives', J
Child Psychol Psychiatry 1996 Jan; 37(1): 89-126.
Bailey A, Luthert P, Dean A, Harding B, Janota I, Montgomery M, Rutter
M, Lantos, 'A clinicopathological study of autism', Brain 1998 May;121 ( Pt
5):889-905
Bakir F, Damluji SF, Amin-Zaki L, Murtadha M, Khalidi A, Al-Rawi NY,
Tikrit S, Dhahir HI, Clarkson TW, Smith JC, Doherty RA, 'Methylmercury
poisoning in Iraq', Science, July 1973, 181;230-241
Baranek G, 'Autism During Infancy: A Retrospective Video Analysis of
Sensory-Motor and Social Behaviors and 9-12 Months of Age', Journal of
Autism and Developmental Disorders, 1999, Vol. 29, No. 3, pp. 213-224
Baron-Cohen S, Ring HA, Wheelwright S, Bullmore ET, Brammer MJ,
Simmons A, Williams SC, 'Social intelligence in the normal and autistic
brain: an fMRI study', Eur J Neuroscience 1999 Jun;11(6):1891-8
Baron-Cohen S, Leslie A, Frith U, 'Does the autistic child have a
'theory of mind'?', Cognition, 1985, No. 21, pp. 37-46
Baron-Cohen S, Allen J, Gillberg C, 'Can autism be detected at 18
months: the needle, the haystack, and the CHAT', Br. J. Psychiatry,
1992;161:839-843
Baron-Cohen S, Tager-Flusberg H, Cohen D, Understanding Other Minds:
Perspectives from Autism, Oxford: Oxford University Press, 1993
Barregard L, Sallsten G, Conradi N, 'Tissue levels of mercury
determined in a deceased worker after occupational exposure', Int Arch Occup
Environ Health 1999 May;72(3):169-173
Bartolome J, Whitmore WL, Seidler FJ, Slotkin TA 1984 'Exposure to
methylmercury in utero: effects on biochemical development of catecholamine
neurotransmitter systems', Life Sciences 1984 Aug 6;35(6):657-670
Bauman ML, Kemper TL, 'Neuroanatomical observations of the brain in
autism', in Bauman & Kemper, eds, The Neuroanatomy of Autism, The Johns
Hopkins University Press
Bauman ML and Kemper TL, Journal of Experimental Neurology, 1988
47:369
Bauman M, Kemper TL, 'Histoanatomic observations of the brain in early
infantile autism', Neurology, 1985;35:866-874
Bernabei P, Camaioni L, Levi G, 'An evaluation of early development in
children with autism and pervasive developmental disorders from home movies:
preliminary findings', Autism, September 1999, Vol. 2, No. 3, 243-258
Bettleheim B, 'A letter from Bruno Bettleheim', Autism Research Review
International, 1989, Vol 3, No. 3, p. 6
Bidet B, Leboyer M, Descours B, Bouvard MP, Benveniste J, 'Allergic
sensitization in infantile autism' (letter), Journal of Autism and
Developmental Disorders, June 1993, Vol. 23, No. 2, pp. 419-420
Binstock T, 'Fragile X and the amygdala: cognitive, interpersonal,
emotional, and neuroendocrine considerations', Dev Brain Dysfunction 1995
8:199-217
Bonnet JJ, Benmansour S, Amejdki-Chab N, Costentin J, 'Effect of
CH3HgCl and several transition metals on the dopamine neuronal carrier;
peculiar behaviour of Zn2+', Eur J Pharmacol 1994 Jan 1;266(1)87-97
Bouilleret V, Boyet S, Marescaux C, Nehlig A, 'Mappingof the
progressive metabolic changes occurring during the development of
hippocampal sclerosis in a model of mesial temporal lobe epilepsy', Brain
Research, 2000, 952:255-262
Brenner RP and Snyder RD, 'Late EEG finding and clinical status after
organic mercury poisoning', Archives of Neurology 1980 May; 37(5):282-284
Bristol M, Cohen D, Costello E, Denckla M, Eckberg T, Kallen R,
Kraemer H, Lord C, Maurer R, McIlvane W, Minshew N, Sigman M, Spence M,
'State of the Science in Autism: Report to the National Institutes of
Health' , Journal of Autism and Developmental Disorders, 1996, Vol. 26, No.
2, pp. 121-157
Bryson SE, 'Brief Report: Epidemiology of Autism', Journal of Autism
and Developmental Disorders, 1996, Vol. 26, No. 2, 165-167
Bryson SE, Smith IM, Eastwood D, 'Obstetrical suboptimality in
autistic children', J Am Acad Child Adolesc Psychi, 1988;27(4)418-22
Bulleit RF, Cui H, 'Methylmercury antagonizes the survival-promoting
activity of insulin-like growth factor on developing cerebellar granule
neurons', Toxicol Appl Pharmacol 1998 Dec;153(2):161-168.
Bulleit RF, Cui H, 'Methylmercury antagonizes the survival-promoting
activity of insulin-like growth factor on developing cerebellar granule
neurons', Toxicol Appl Pharmacol 1998 Dec;153(2):161-168
Cagiano R, De Salvia MA, Renna G, Tortella E, Braghiroli D, Parenti C,
Zanolie P, Baraldi M, Annau Z, Cuomo V, 'Evidence that exposure to methyl
mercury during gestation induces behavioral and neurochemical changes in
offspring of rats', Neurotoxicol Teratol 1990 Jan-Feb;12(1):23-28
Camerino , Cassitto M, 'Behavior of Some Psychological Parameters of a
Population of a Hg Extraction Plant', Journal of Clinical Toxicology, 1981,
Vol. 18 (11), pp. 1299-1309
Capps L, Kehres J, Sigman M, 'Conversational abilities among children
with autism and children with developmental delays', Autism, 1998
Dec;2(4):325-44
Carlsson ML, 'Hypothesis: is infantile autism a hypoglutamatergic
disorder? Relevance of glutamate - serotonin interactions for
pharmacotherapy', Journal of Neural Transmitters 1998 105(4-5):525-535
Carlsson ML, Martin P, Nilsson M, Sorensen SM, Carlsson A, Waters S,
Waters N, 'The 5-HT2A receptor antagonis M100907 is more effective in
counteracting NMDA antagonist- than dopamine agonist-induced hyperactivity
in mice', J Neural Transm 1999; 106(2):123-129
Carpenter PK, Morris D, 'Association of acrocyanosis with Asperger's
syndrome', Journal of Mental Deficiency Research, 1990, 34, pp. 97-90
Carroll L, Alice in Wonderland, W.W. Norton & Company, 1992, 1971
CDC, 'Recommendations Regarding the Use of Vaccines That Contain
Thimerosal as a Preservative', MMWR November 5, 1999 / 48(43); 996-998
CDC, 'Thimerosal in vaccines: a joint statement of the Amercian
Academy of Pediatrics and the Public Health Service', MMWR Morb Mortal Wkly
Rep 1999 July 9; 48(26):563-565
CDC, 'Record Immunization Rate, 80% of Kids Getting Vaccinated',
Associated Press, September 23, 1999
Cesaroni L, Garber M, 'Exploring the experience of autism through
firsthand accounts', Journal of Autism and Developmental Disorders, 1991
Sep;21(3):303-13
Chapman AG, Elwes RD, Millan MH, Polkey CE, Meldrum BS, 'Role of
Glutamate and Aspartate in Epileptogenesis; Contribution of Microdialysis
Studies in Animal and Man', Epilepsy Res Suppl, 1996, Vol. 12, pp. 239-246
Cheek DB, 'Acrodynia', in Brennemann's Practice of Pediatrics, Chapter
17D, from Pink Disease website,
www.users.bigpond.com/difarnsworth/pcheek42.htm
Chodorowski Z, Sein Anand J, Nowicki A, Galant K, 'Subcutaneous
self-injection and oral self-administration of metallic mercury - case
report', Przegl Lek 1997;54(10):759-762
Chu CC, Huang CC, Ryu SJ, Wu TN, 'Chronic inorganic mercury induced
peripheral neuropathy', Acta Neurology Scandanavia 1998 Dec;98(6):461-465
Chugani DC, Muzik O, Behen M, Rothermel R, Janisse JJ, Lee J, Chugani
HT, 'Developmental Changes in Brain Serotonin Synthesis Capacity in Autistic
and Nonautistic Children', Ann Neurol 1999; 45:
Church C, Coplan J, 'The High Functioning Autistic Experience: Birth
to Preteen Years', Journal of Pediatric Health Care, 1995, Vol. 9, pp.22-29
Clarke D, Baxter M, Perry D, Prasher V, 'The diagnosis of affective
and psychotic disorders in adults with autism: seven case reports', Autism,
1999 Jun;3(2):149-164
Clarkson TW, 'Mercury: Major Issues in Environmental Health',
Environmental Health Perspectives vol. 100, pp. 31-38, 1992
Clarkson, T. 1997 'The Toxicology of Mercury', Critical Reviews in
Clinical Laboratory Sciences, 34(3): 369-403 (1997)
Clarkson, TW, 'Mercury - an element of mystery', The New England
Journal of Medicine 1990 Oct 18
Clarkson,T.W, 1993, 'Molecular and ionic mimicry of toxic metals',
Annu. Rev. Pharmacol. Toxicol. 32:545-571
Cloarec S, Deschenes G, Sagnier M, Rolland JC, Nivet H, 'Arterial
hypertension due to mercury poisoning: diagnostic value of captopril', Arch
Pediatr 1995 Jan;2(1):43-46
Close AH, Guo TL, Shenker BJ, 'Activated human T lymphocytes exhibit
reduced susceptibility to methylmercury chloride-induced apoptosis', Toxicol
Sci 1999 May;49(1):68-77
Coccini T, Randine G, Candura SM, Nappi RE, Prockop LD, Manzo L,
'Low-Level Exposure to Methylmercury Modifies Muscarinic Cholinergic
Receptor Binding Characteristics inRat Brain and Lymphocytes: Physiologic
Implications and New Opportunities in Biologic Monitoring', Environ Health
Perspect, 2000 Jan;108(1):29-33
Coleman M, 'Nutritional treatments currently under investigation in
autism', Clinical Nutrition, Sept/Oct 1989, Vol. 8, No. 5, pp. 210-212
Comi AM, Zimmerman A et al, 'Familial clustering of autoimmune
disorders and evaluation of medical risk factors in autism', Journal of
Child Neurology, 1999, Vol. 14, pp. 388-394
Connolly AM, et al, 'Serum autoantibodies to brain in Landau-Kleffner
variant, autism, and other neurologic disorders', Journal of Pediatrics, May
1999, Vol. 134, No. 5, pp. 607-613
Cook EH, 'Autism: review of neurochemical investigation', Synapse,
1990, 6:292-308
Courchesne E, et al,'More evidence links autism, cerebellar defects',
reviewed in Autism Research Review International, 1994, Vol. 8, No. 2, pp.
1&7
Courchesna E, Press GA, Young-Courchesne R, 'Parietal lobe
abnormalities detected with MR in patients with infantile autism', AJR Am J
Roentgenol 1993 Feb;160(2):387-93
Courchesne E, 'Brainstem, cerebellar and limbic neuroanatomical
abnormalities in autism', Current Opin Neurobiol 1997 Apr;7(2):269-78
Courchesne E, Saitoh O, Townsend J, Yeung-Courchesne R, Lincoln AJ,
Schreibman L, Haas RH, Press GA, 'Cerebellar Abnormalities in Autism: New
Evidence and A Re-Analysis of Old Evidence', pp. 211-214
Courchesne E, Yeung-Courchesne R, Elmasian R, Grillon C,
'Pathophysiologic findings in non-retarded autism and receptive
developmental language disorder', Journal of Autism and Developmental
Disorders, 1989; 19:1-17
Courchesne E, Yeung-Courchesne R, Press GA, Hesselink JR, Jernigan TL,
'Hypoplasia of cerebellar vermal lobules VI and VII in autism', New England
Journal of Medicine 1988 318:1349-1354
Courchesne E, Yeung-Courchesne R, Press GA, Hesselink JR, Jernigan TL,
'Hypoplasia of cerebellar vermal lobules VI and VII in autism', New England
Journal of Medicine, May 26, 1998; pp. 1349-1354
Courchesne E, reported in The New York Times, 'Science Times' section,
Dec 28, 1999, by Blakeslee S
Cox NH, Forsyth A, 'Thiomersal allergy and vaccination reactions',
Contact Dermatitis 1988:18:229-233
Creel DJ, Crandall AS, Pingree C, Ritvo ER, 'Abnormal
electroretinograms in autism', Clinical Vision Science 1989 4(1):85-88
Cuomo V, Ambrosi L, Annau Z, Cagiano R, Brunello N, Racagni G 1984,
'Behavioral and neurochemical changes in offspring of rats exposed to methyl
mercury during gestation', Neurobehavior Toxicology Teratol 1984
May-June;6(3):249-254
D'Eufemia P, Celli M, Finocchiaro R, Pacifico L, Viozzi L, Zaccagnini
M, Cardi E, Giardini O, 'Abnormal intestinal permeability in children with
autism', Acta Pædiatr 1996:85:1076-1079
D'Eufemia P, Finocchiaro R, Celli M, Viozzi L, Monteleone D, Giardini
O, 'Low serum tryptophan to large neutral amino acids ratio in idiopathic
infantile autism', Biomed. & Pharmacother., 1995, Vol. 49, pp. 288-292
Dales LD, 'The Neurotoxicity of Alkyl Mercury Compounds', American
journal of Medicine, August 1972, Vol. 53, 219-232
Dally A, 'The Rise and Fall of Pink Disease', Wellcome Institute for
the History of Medicine, 1997, available at
www.users.bigpond.com/difarnsworth
Dathan JG, 'Pink Disease-Ten Years After (The Epilogue), British
Medical Journal, 1965, Vol 1, pp. 1181-1182
Dave V, Mullaney KJ, Goderie S, Kimelberg HK, Aschner M, 'Astrocytes
as mediators of methylmercury neurotoxicity: effects on D-aspartate and
serotonin uptake', Dev Neurosci 1994;16(3-4):222-231
Davis LE, Kornfeld M, Mooney HS, Fiedler KJ, Haaland KY, Orrison WW,
Cernichiari E, Clarkson TW, 'Methylmercury poisoning: long term clinical,
radiological, toxicological, and pathological studies of an affected
family',
Annals of Neurology 1994 35:6 680-688
Dawson G, 'Brief Report: Neuropsychology of Autism: A Report on the
State of the Science', Journal of Autism and Developmental Disorders, 1996,
Vol. 26, No. 2, 179-184
Deb S and Thompson B, 'Neuroimaging in autism', British Journal of
Psychiatry 1998 Oct 173:299-302
DelGiuidce-Asch G, Hollander E, 'Altered immune function in autism',
CNS Spectrums: International Journal of Neuropsychiatric Medicine, 1997,
2:61-68
DeLong GR, 'Autism: new data suggest a new hypothesis', Neurology,
March 1999, Vol. 52, No. 5, pp. 911-916
Deutsch S, Campbell M, Sachar E, Green W, David R, 'Plasma growth
hormone response to oral L-dopa in infantile autism', Journal of Autism and
Developmental Disorders, June 1985, Vol. 15, No. 2, pp. 205-212
Deyab P, Gochfeldbc M, Reuhlabca K, 'Developmental Methylmercury
Administration Alters Cerebellar PSA-NCAM expression and Golgi
sialyltransferase Activity', 1999
Diner Barry, M.D., Brenner Barry, M.D.,Toxicity, Mercury, 1998
Edelson MG, Edelson SM, Jung S, 'Assessing the Intelligence of
Individuals with Autism: A Cross-Cultural Replication of the Usefulness of
the TONI', Focus on Autism and Other Developmental Disabilities, Winter
1998, Vol. 13, No. 4, 221-227
Edelson MG, Schubert DT, Edelson SM, 'Factors Predicting Intelligence
Scores on the TONI in Individuals with Autism', Focus on Autism and Other
Developmental Disabilities, Spring 1998, Vol. 13, No. 1, 17-26
Edelson SB, Cantor DS, 'Autism: xenobiotic influences', Toxicol Ind
Health, 1998 Jul-Aug;14(4):553-563
Egan, William M. 1999 'Thimerosal in Vaccines', presentation to the
FDA, September 14, 1999
Eisenmayer R et al, 'Delayed language onset as a predictor of clinical
symptoms in pervasive developmental disorders', Journal of Autism and
Developmental Disorders, 1998 Dec 28(6):527-33
El-Fawal HA, Waterman SJ, De Feo A, Shamy MY, 'Neuroimmunotoxicology:
Humoral Assessment of Neurotoxicity and Autoimmune Mechanisms', Environ
Health Perspect 1999 Oct;107(Suppl 5):767-775
El-Fawal HA, Waterman SJ, DeFeo A, Shamy MY, 'Neuroimmunotoxicology:
Humoral Assessment of Neurotoxicity and Autoimmune Mechanisms', Environ
Health Perspect 1999 Oct;107(Suppl5):767-775
Elferink JG Thimerosal: a versatile sulfhydryl reagent,calcium
mobilizer, and cell function-modulating agent.Gen Pharmacol 1999
Jul;33(1):1-6
Environmental Protection Agency (EPA), lead authors - Hassett-Sipple
B, Swartout J, Schoeny R, 'Vol. V - Health Effects of Mercury and Mercury
Compounds', Mercury Study Report to Congress, December 1997
Ernst M, Zametkin AJ, Matochik JA, Pascualvaca D, Cohen RM, 'Low
medial prefrontal dopaminergic activity in autistic children', Lancet 1997
Aug 30;350(9078):638
Eto K, Takizawa Y, Akagi H, Haraguchi K, Asano S, Takahata N, Tokunaga
H, 'Differential diagnosis between organic and inorganic mercury poisoning
in human cases - the pathologic point of view', Toxicol Pathol 1999
Nov-Dec;27(6):664-671
Fagala GE,Wigg CL, 'Psychiatric Manifestions of Mercury Poisoning', J.
Am. Acad. Child. Adolesc. Psychiatry, March 1992, 31(2):306-311.
Fagan DG, Pritchard JS, Clarkson TW, Greenwood MR, 'Organ mercury
levels in infants with omphaloceles treated with organic mercurial
antiseptic', Archives of Disease in Childhood, 1977 52:962-964
Farnsworth D, 'Pink Disease Survey Results', Pink Disease Support
Group Site, 1997 www.users.bigpond.com/difarnsworth
Faro LR, Duran R, do Nascimento JL, Alfonso M, Picanco-Diniz CW,
'Effects of methyl mercury on the in vivo release of dopamine and its acidic
metabolites DOPAC and HVA from Striatum of rats', Ecotoxicol Environ Saf
1997 Nov;38(2):95-98
Faro LRF, Nascimento JLM do, Alfonso M, Duran R, 'Acute Administration
of Methylmercury Changes In Vivo Dopamine Release from Rat Striatum',
Bulletin of Environmental Contamination Toxicology, 1998 60:632-638
FDA, HHS, 'Mercury Containing Drug Products for Topical Antimicrobial
Over-the-Counter Human Use; Establishment of a Monograph', Federal Register,
January 5 1982, Vol. 47, No. 2, 436-442
FDA, 'Mercury Compounds in Drugs and Food', 98N-1109, November 16,
1999
Feldman R, 'Neurological Manifestations of Mercury Intoxication',
Journal of Occupational Neurology, 1982, Vol. 66, pp. 201-209
Filipek P, Accardo P, Baranek G, Cook E, Dawson G, Gordon B, Gravel J,
Johnson C, Kallen R, Levy S, Minshew N, Prizant B, Rapin I, Rogers S, Stone
W, Teplin S, Tuchman R, Volkmar F, 'The Screening and Diagnosis of Autistic
Spectrum Disorders', Journal of Autism and Developmental Disorders, 1999,
Vol. 29, No. 6, pp. 439-484
Filipek PA, Accardo PJ, Baranek GT, Cook Jr. EH, Dawson G, Gordon B,
Gravel JS, Johnson CP, Kallen RJ, Levy SE, Minshew NJ, Prizant BM, Rapin I,
Rogers SJ, Stone WL, Teplin S, Tuchman RF, Volkmar FR, 'The Screening and
Diagnosis ot Autistic Spectrum Disorders', Journal of Autism and
Developmental Disorders, 1999, Vol. 29, No. 6, 439-484
Finegan J, Quarrington B, 'Pre-, peri-, and neonatal factors and
infantile autism', J Child Psychol Psychi, 1979; 20.119-128
Florentine MJ and Sanfilippo II DJ, 'Grand Rounds: Elemental mercury
poisoning', Clinical Pharmacy 1991 Mar 10:213-221
Fombonne E, Rogé B, Claverie J, Courty S, Frémolle J, 'Microcephaly
and Macrocephaly in Autism' Journal of Autism and Developmental Disorders,
1999, Vol. 29, No. 2, 113-119
Food and Drug Administration, 1997 'Status of Certain Additional
Over-the-Counter Drug Category II and III Active Ingredients', Docket Nos.
75N-183F, 75N-183D, and 80N-0280, October 19,1998
Fournier L, Thomas, G, Garnier, R, Buisine, A, Houze, P, Pradier, F,
and Dally, S 1988, '2,3-Dimercaptosuccinic Acid Treatment of Heavy Metal
Poisoninig in Humans', Medical Toxicology 3: 499-505 (1988)
Frackelton JP, Christensen RL, 'Mercury Poisoning and Its Potential
Impact on Hormone Regulation and Aging: Preliminary Clinical Observations
Using a New Therapeutic Approach', Journal of Advancement in Medicine 1998
Spring 11(1):9-25
Fredriksson A, Dencker L, Archer T, Danielsson BGR, ''Prenatal
coexposure to metallic mercury vapour and methylmercury produce interactive
behavioural changes in adult rats', Neurotoxicol Teratol 1996 19(2):129-134
Fuchs J, Packer L, Zimmer G, Lipoic Acid in Health and Disease, Marcel
Dekker, Inc., 1997
Fuchs J, Schöfer H, 'Redox Modulation of Signal Transduction and Gene
Expression in HIV Infection: The Role of the Antioxidant Lipoate', Lipoic
Acid in Health and Disease, Fuchs, Packer, & Zimmer (eds), Marcel Dekker,
Inc., 1997, 435-454
Fudenberg HH, 'Dialysable Lymphocyte Extract (DLyE) in Infantile Onset
Autism: A Pilot Study', Biotherapy (1996) 9:143-147
Fukino H, Hirai M, Hsueh YM, Yamane Y,'Effect of zinc pretreatment on
mercuric chloride-induced lipid peroxidation in the rat kidney', Toxicol
Appl Pharmacol 1984 May;73(3):395-401
Gaffney GR, Kuperman S, Tsai LY, Minchin S, 'Morphological evidence
for brainstem involvement in infantile autism', Biological Psychiatry,
September 1988, 24:578-586
Gedye A, 'Anatomy of self-injurious, stereotypic, and aggressive
movements: evidence for involuntary explanation', Journal of Clinical
Psychology, November 1992, Vol. 48, No. 6, pp. 766-778
Gilbert SG, Grant-Webster KS, 'Neurobehavioral effects of
developmental methymercury exposure', Environmental Health Perspectives,
1995 Sept; 103 Suppl 6:135-142
Gillberg C, Coleman M, The Biology of the Autistic Syndromes - 2nd
Edition, Mac Keith Press, 1992
Gillberg C, Dev Med Child Neurol 37, 23-45 (1995)
Gillberg C, Gillberg IC, 'Infantile Autism: a total population study
of reduced optimality in the pre-, peri- and neonatal period', Journal of
Autism and Developmental Disorders, 1983, Vol 13, No. 2, pp. 153-166
Gillberg C, Svennerholm L, 'CSF monoamines in autistic syndromes and
other pervasive dev. disorders of early childhood', British Jour. of
Psychiatry, 1987, No. 151, pp. 89-94
Gillberg C, Wing L, 'Autism: not an extremely rare disorder', Acta
Psychiatr Scand 1999 Jun;99(6)399-406
Goldberg M, Mena I, Miller B, 'Frontal and temporal lobe dysfunction
in autism and other related disorders: ADHD and OCD', Latin American Journal
of Nuclear Medicine, July 1999, available online:
http://www.alabimnjournal.cl
Golse B, Debray-Ritzen P, Durosay P, Puget K, Michelson AM,
'Alterations in two enzymes: superoxide dismutase and glutathion peroxidase
in developmental infantile psychosis', Revue Neurologic (Paris) 1978
Nov;134(11):699-705
Gosselin RE, Smith RP, Hodge HC, Clinical Toxicology of Commercial
Products, Section III, Therapeutic Index, 'Mercury', (5th edition),
Baltimore, Williams & Wilkins, 1984: pp262-271.
Grandin T, 'Brief Report: Response to National Institutes of Health
Report', Journal of Autism and Developmental Disorders, 1996, Vol. 26, No.
2, 185-187
Grandin T, 'The Learning Style of People With Autism: An
Autobiography',
Teaching Children with Autism, Kathleen Ann Quill, 33-52
Grandjean P, Budtz-Jorgensen E, White RF, Jorgensen PJ, Weihe P, Debes
F, Keiding N, 'Methylmercury exposure biomarkers as indicators of
neurotoxicity in children aged 7 years', Am J Epidemiol 1999 Aug 1;
150(3):301-305
Grandjean P, Guldager B, Larsen IB, Jergensen PJ, Holmstrup P,
'Placebo Response in Environmental Disease', JOEM 1997 August, Vol. 38, No.
8,707-714
Grandjean P, Weihe P, White RF, Debes F, 'Cognitive performance of
children prenatally exposed to "safe" levels of methylmercury',
Environmental Research 1998 May; 77(2): 165-172
Grandjean P, White RF, Nielsen A, Cleary D, de Oliveira Santos EC,
'Methylmercury neurotoxicity in Amazonian children downstream from gold
mining', Environ Health Perspect 1999 Jul;107(7):587-591
Grundt IK, Stensland E, Syverson TL, 'Changes in fatty acid
composition of myelin cerebrosides after treatment of the developing rat
with methylmercury chloride and diethylmercury'. J Lipid Res, 1980
Feb;21(2):162-168
Gunderson, VM, Grant KS, Burbacher TM, Fagan 3rd JF, Mottet, NK, 'The
effect of low-level prenatal methyl mercury exposure on visual recognition
memory in infant crab-eating macaques', Child Dev., 1986, 57(4):1076-1083
Gunderson, VM, Grant KS, Burbacher TM, et al, 'Visual recognition
memory deficits in methyl mercury exposed Macaca fascicularis infants',
Neurotoxicol Teratol., 1988, 10(4):373-379
Gupta S, Aggarwal S, Heads C, 'Brief Report: Dysregulated Immune
System in Children with Autism: Beneficial Effects of Intravenous Immun
Globulin on Autistic Characteristics', Journal of Autism and Developmental
Disorders, 1996, Vol. 26, No. 4, 439-452
Gupta S, Aggarwal S, Rashanravan B, Lee T, 'Th1- and Th2-like
cytokines in CD4+ and CD8+ T cells in autism', J Neuroimmunol 1998 May
1;85(1):106-109
Haeney MR, Carter GF, Yeoman WB, Thompson RA, 'Long-term parental
exposure to mercury in patients with hypogammaglobulinaemia', British
Medical Journal 1979 2:12-14
Hagerman RJ, 'Possible similarities between the fragile X and Asperger
syndrome', American Journal of Diseases of Children, 1987;141:601-602
Halsey NA, 'Perspective on the use of thimerosal-containing vaccines',
presentation at the National Vaccine Advisory Committee Workshop on
Thimerosal and Vaccines, August 11-12, 1999, available on Institute of
Vaccine Safety website, www.vaccinesafety.edu
Halsey NA, 'Limiting Infant Exposure to Thimerosal in Vaccines and
Other Sources of Mercury', JAMA, November 10, 1999, Vol. 282, No. 18
Hartman DE, 'Missed diagnoses and misdiagnoses of environmental
toxicant exposure', Diagnostic Dilemmas, Part I, 1998 Sep;21(3):659-671
Hashimoto T, Tayama M, Miyazaki M, Sakurama N, Yoshimoto T, Murakawa
K, Kuroda Y, 'Reduced brainstem size in children with autism', Brain &
Development, 1992, Vol. 14, No. 2, pp. 94-97
Hashimoto T, Tayama M, Murakawa K, Yoshimoto T, Miyazaki M, Harada M,
Kuroda Y, 'Development of the brainstem and cerebellum in autistic
patients',
Journal of Autism and Developmental Disorders, 1995, Vol. 25, No. 1, pp.
1-18
Haznedar MM, Buchsbaum MS, Metzger M, Solimando A, Spiegel-Cohen J,
Hollander E, 'Anterior Cingulate Gyrus Volume and Glucose Metabolism in
Autistic Disorder', Amercian Journal of Psychiatry 1997 Aug 154(8):1047-1050
Hepatitis Control Report, 'Uproar over a little-known preservative,
thimerosal, jostles U.S. hepatitis B vaccination policy', Summer 1999, Vol.
4, No. 2
Hollander E, Kaplan A, Cartwright C, Reichman D, 'Venlafaxine in
children, adolescents, and young adults with autism spectrum disorders: an
open retrospective clinical report', J Child Neurol, 2000, Feb;15(2):132-135
Hoon AH and Riess AL, 'The mesial-temporal lobe and autism: case
report and review', Developmental Medicine and Child Neurology 1992
34:252-265
Horvath K, Papadimitriou JC, Rabsztyn A, Drachenberg C, Tildon JT,
'Gastrointestinal abnormalities in children with autistic disorder', Journal
of Pediatrics 1999 Nov 135(5):559-563
Hoshino Y, Watanabe M, Kumashiro H, 'The hypothalamo-pituitary
function in autistic children: the change of serum 5HT, plasma human growth
hormone, prolactin level after L-5HTP loading', Neurosciences, 1984, Vol.
10, pp. 285-291
Hoshino Y, Watanabe M, Kumashiro H, 'The TRH and LH-RH loading test in
autistic children', Journal of Medical Science, 1985, Vol. 31, No. 1
Howlin P, 'Outcome in adult life for more able individuals with autism
or Asperger syndrome', Autism 2000 Mar;4(1):63-84
Hrdina PD, Peters DA, Singhal RL 1976, 'Effects of chronic exposure to
cadmium, lead and mercury of brain biogenic amines in the rat', Research
Communications in Chemistry, Pathology and Pharacology 1976
Nov;15(3):483-493
Hu H, Abedi-Valugerdi M, Moller G, 'Pretreatmet of lymphocytes with
mercury in vitro induces a response in T cells from genetically determine
low-responders and a shift of the interleukin profile', Immunology, 1997
90:198-204
Hu H, Möller G, Abedi-Valugerdi M, 'Major histocompatibility complex
class II antigens are required for both cytokine production and
proliferation induced by mercuric chloride in vitro', J Autoimmun, Oct 1997,
10(5):441-446
Hu H, Moller G, Abedi-Valugerdi M, 'Mechanism of mercury-induced
autoimmunity: both T helper 1- and T helper 2-type responses are involved',
Immunology, March 1999, 96(3):348-357
Hua MS, Huang CC, Yang YJ, 'Chronic elemental mercury intoxication:
neuropsychological follow up case study', Brain Inj 1996 May;10(5):377-84
Hultman P, Hansson-Georgiadis H, 'Methyl mercury-induced autoimmunity
in mice', Toxicol Appl Pharmacol, Feb 1, 1999, 154(3):203-211
Hultman P, Nielsen JB, 'The effect of toxicokinetics on murine
mercury-induced automimunity', Environ Res, May 1998, 77(2):141-148
Hultman P, Turley SJ, Eneström S, Lindh U, Pollard KM, 'Murine
genotype influences the specificity, magnitude and persistence of murine
mercury-induced autoimmunity', J Autoimmun, April 1996, 9(2): 139-149
Hussain S, Atkinson A, Thompson SJ, Khan AT, 'Accumulation of mercury
and its effect on antioxidant enzymes in brain, liver, and kidneys of mice',
J Environ Sci Health B 1999 Jul;34(4):645-660
Ikeda M, Komachi H, Sato I, Himi T, Yuasa T, Murota S, 'Induction of
neuronal nitric oxide synthase by methylmercury in the cerebellum', Journal
of Neuroscience Research 1999 Feb 1;55(3):352-356.
Ikeda M, Komachi H, Sato I, Himi T, Yuasa T, Murota S, 'Induction of
neuronal nitric oxide synthase by methylmercury in the cerebellum', J
Neurosci Res 1999 Feb 1;55(3):352-356
Ilback NG, 'Effects of methyl mercury exposure on spleen and blood
natural-killer (NK) cell-activity in the mouse', Toxicology, 1991,
67(1):117-124
Islam MS, Berggren PO, Larsson O, 'Sulfhydryl oxidation induces rapid
and reversible closure of the ATP-regulated K+ channel in the pancreatic
beta cell', FEBS Lett 1993 Mar 15;319(1-2):128-132
Jaffe JS, et al, 'Functional abnormalities of CD8+ t cells define a
unique subset of patients with common variable immunodeficiency', Blood,
1993, 82.1.192-2001
Jaselskis C, Cook E, Fletcher K, and Bennett L, 'Clonidine treatment
of hyperactive and impulsive children with autistic disorder', Journal of
Clinical Psychopharmacology 1992
Johansson U, Hansson-Georgiadis H, Hultman P, 'The genotype determines
the B cell response in mercury-treated mice', Int Arch Allergy Immunol, Aug
1998, 116(4):295-305
Joselow MM, Louria DB, Browder AA, 'Mercurialism: Environmental and
Occupational Aspects', Annals of Internal Medicine 1972 76:119-130
Joseph SK, Ryan SV, Pierson S, Renard-Rooney D, Thomas AP, 'The effect
of mersalyl on inositol trisphosphate receptor binding and ion channel
function', J Biol Chem 1995 Feb 24;270(8):3588-3593
Journal of Autism and Developmental Disorders, 1995, Vol. 25, No. 2
Kabuto M,'Chronic effects of methylmercury on the urinary excretion of
catecholamines and their responses to hypoglycemic stress', Arch Toxical
1991;65(2):164-167
Kanner L, 'Autistic Disturbances of Affective Contact', The Nervous
Child 1942-1943, Vol. 2, No. 3, 217-250
Karhapaa l, Titievsky A, Kaila K, Tornquist K, 'Redox modulation of
calcium entry and release of intracellular calcium by thimerosal in GH4C1
pituitary cells', Cell Calcium 1996 Dec;20(6):447-457
Kark RA, Poskanzer DC, Bullock JD, Boylen G. 'Mercury poisoning and
its treatment with N-acetyl-D, L-penicillamine', New England Journal of
Medicine 1971;285:10-16
Kates WR, Mostofsky SH, Zimmerman AW, Mazzocco MM, Landa R, Warsofsky
IS, Kaufmann WE, Reiss AL, 'Neuroanatomical and neurocognitive differences
in a pair of monozygous twins discordant for strictly defined autism', Ann
Neurol 1998 Jun; 43(6):782-791
Kinoshita Y, Ohnishi A, Kohshi K, Yokota A, 'Apparent diffusion
coefficient on rat brains and nerves intoxicated with methylmercury',
Environ Res 1999 May;80(4):348-354.
Klin A, Sparrow SS, de Bildt A, Cicchetti DV, Cohen DJ, Volkmar FR, 'A
Normed Study of Face Recognition in Autism and Related Disorders', Journal
of Autism and Developmental Disorders December 1999 29:6 499-508
Koegel LK, Koegel RL, Smith A, 'Variables Related to Differences in
Standardized Test Outcomes For Children with Autism', Journal of Autism and
Developmental Disorders, 1997, Vol. 27, No. 3, 233-243
Koos BJ and Longo LD, 'Mercury toxicity in the pregnant woman, fetus,
and newborn infant', American Journal of Obstetrics and Gynecology 1976 Oct
126(3):390-406
Kugler B, 'The differentiation between autism and Asperger syndrome',
Autism, 1998 Mar;2(1):11-32
Kurita H, 'Infantile autism with speech loss before the age of thirty
months', Journal of the American Academy of Child Psychiatry, 1985, Vol. 24,
Issue 2, pp. 191-196
LaCamera RG, LaCamera AC, 'Routine Health Care', Handbook of Autism
and Pervasive Developmental Disorders, Cohen D, Donnellan AM, Paul R, eds,
1987 by John Wiley & Sons, Inc., p584-595
Larkfors L, Oskarsson A, Sundberg J, Ebendal T, 'Methylmercury induced
alterrations in the nerve growth factor level in the developing brain',
Brain Res Dev Brain Res 1991 Oct 21; 62(2) 287-291
Leboyer M, Philippe A, Bouvard M, Guilloud-Bataille M, Bondoux D,
Tabuteau F, Feingold J, Mouren-Simeoni MC, Launay JM, 'Whole blood serotonin
and plasma beta-endorphin in autistic probands and their first-degree
relatives', Biol Psychiatry 1999 Jan 15;45(2):158-63
Lewine 'Magnetoenchalography in Children with an Autistic Epileptiform
Regression', J Pediatrics, 1999 405-418
Lewis MH, 'Brief Report: Psychopharmacology of Autism Spectrum
Disorders', Journal of Autism and Developmental Disorders, 1996, Vol. 26,
No. 2, 231-235
Li S, Thompson SA, Woods JS, 'Localization of gamma-glutamylcysteine
synthetase mRNA expression in mouse brain following methylmercury treatment
using reverse transcription in situ PCR amplification', Toxicol Appl
Pharmacol, Sept 1996, 140(1):180-187
Lombard J, 'Autism: a mitochondrial disorder?', Medical Hypotheses
1998 Jun;50(6):497-500
Lorscheider FL, Vimy MJ, Summers AO, 'Mercury exposure from "silver"
tooth fillings: emerging evidence questions a traditional dental paradigm',
The FASEB Journal, April 1995, Vol. 9, 504-508
Lowell JA, Burgess S, Shenoy S, Curci JA, Peters M, Howard TK,
'Mercury Poisoning Associated with High-Dose Hepatitis-B Immune Globulin
Administration After Liver Transplantation for Chronic Hepatitis B', Liver
Transplantation and Surgery, Nov 1996, Vol. 2, No. 6, 475-478
Magos L, Brown AW, Sparrow S, Bailey E, Snowden RT, Skipp WR, 'The
comparative toxicology of ethyl- and methylmercury', Archives of Toxicology,
1985 Sep;57(4):260-267
Malhotra S, Gupta N, 'Childhood Disintegrative Disorder', Journal of
Autism and Developmental Disorders Dec 1999 29;6 491-498
Markovich D, Knight D, 'Renal Na-Si Cotransporter NaSi-1 is inhibited
by heavy metals', American Journal of Renal Physiology, February 1998, Vol.
274, No. 2, pp283-289
Marty MS, Atchison WD, 'Elevations of intracellular Ca2+ as a probable
contributor to decreased viability in cerebellar granule cells following
acute exposre to methyl mercury', Toxicol Appl Pharmacol 1998 May'
150(1):98-105
Matheson DS, Clarkson TW, Gelfand EW, 'Mercury toxicity (acrodynia)
induced by long-term injection of gammaglobulin', Journal of Pediatrics
1980;97(1):153-155.
Mathiesen T, Ellingsen DG, Kjuus H, 'Neuropsychological effects
associated with esposure to mercury vapor among former chloralkali workers',
Scand J Work Environ Health, 1999, Aug:25(4):342-350
Mattsson JR, Miller E, Alligood JP, Koering JE, Levin SG, 'Early
effects of methylmercury on the visual evoked response of the dog',
Neurotoxicology 1981 Nov;2(3):499-514
McClelland RJ, Eyre D, Watson D, Calvert J, 'A neurophysiological
study of autistic children', Electroencephalography and Clinical
Neurophysiology, Sept. 1985, Vol. 61, p. 16
McClelland RJ, Eyre DG, Watson D, Calvert GJ, Sherrard E, British
Journal of Psychiatry, 1992, 160: 659-663
McDougle C, Psycholopharmacology, Handbook of Autism and Pervasive
Developmental Delay, 2nd ed. New York: John Wiley and Sons, 1997;707:729
McDougle CJ, Brodkin ES, Yeung PP, Naylor ST, Cohen DJ, Price LH,
'Risperidone in adults with autism or pervasive developmental disorder',
Journal of Child and Adolescent Psychopharmacology, 1995, Vol. 5, No. 4, pp.
273-282
McDougle CJ, Homes JP, Bronson MR, Anderson GM, Volkmar FR, Price LH,
Cohen DJ, 'Risperidone treatment of children and adolescents with pervasive
developmental disorders: A prospective open-label study', Journal of the
American Academy of Child and Adolescent Psychiatry, 36, 685-693
McKay SJ, Reynolds JN, Racz WJ, 'Effects of mercury compounds on the
spontaneous and potassium-evoked release of [3H]dopamine from mouse striatal
slices', Canadian Journal of Physiology and Pharmacology 1986 Dec
64(12):1507-1514
McKeown-Eyssen GE, Ruedy J, Neims A, 'Methyl mercury exposure in
northern Quebec: II. Neurologic findings in children', Am. J. Epidemiol.,
1983, 118:470-479
Merck & Co., Inc., 'Merck Launches Preservative-Free Hepatitis-B
Vaccine', press release, Sept 9, 1999
Messahel S, Pheasant AE, Pall H, Ahmed-Choudhury J, Sungum-Paliwal RS,
Vostanis P, 'Urinary levels of neopterin and biopterin in autism', Neurosci
Lett 1998 Jan 23;241(1):17-20
Minnema DJ, Cooper GP, Greenland RD, 'Effects of methylmercury on
neurotransmitter release from rat brain synaptosomes', Toxicology and
Applied Pharmacology 1989 Jul 99(3):510-521
Minshew NJ, 'Brief Report: Brain Mechanisms in Autism: Functional and
Structural Abnormalities', Journal of Autism and Developmental Disorders,
1996, Vol. 26, No. 2, 205-209
Moreno H, Borjas L, Arrieta A, Saez L, Prassas A, Estevez J, Bonilla
E, 'Clinical heterogeneity of the autistic syndrome: a study of 60 families'
(Spanish), Invest Clin 1992;33(1):13-31
Moreno-Fuenmayor H, Borjas L, Arrieta A, Valera V, Socorro-Candanoza
L, 'Plasma excitory amino acids in autism', Invest Clin 1996
Jun;37(2):113-128
Muris P, Steerneman P, Merckelbach H, Holdrinet I, Meesters C,
'Comorbid anxiety symptoms in children with pervasive developmental
disorders', Journal of Anxiety Disorders, 1998, Vol. 12, No. 4, pp. 387-393
Musiek FE, Hanlon DP, 'Neuroaudiological effects in a case of fatal
dimethylmercury poisoning', Ear Hear 1999 Jun;20(3):271-275
Nass R, Gross A, Devinsky O, 'Autism and autistic epileptiform
regression with occipital spikes',Dev Med Child Neurol 1998 Jul;40(7):453-8
'Neville's (a Pinkie) Recollection of Pink Disease', Pink Disease
Support Group, www.users.bigpond.com/difarnsworth
Nielsen JB and Hultman P, 'Experimental studies on genetically
determined susceptibility to mercury-induced autoimmune response', Renal
Failure 1999 21(3&4):343-348
Nishio H, Nezasa K, Hirano J, Nakata Y, 'Effects of thimerosal, an
organic sulfhydryl modifying agent, on serotonin transport activity into
rabbit blood platelets', Neurochemistry International 1996 29(4):391-396
Nordin V, Gillberg C, 'Autism Spectrum disorders in children with
physical or mental disability or both. I: Clinical and epidemiological
aspects', Dev Med Child Neurol 1996 Apr; 38(4):297-313
Nowell MA, Hackney DB, Muraki AS, Coleman M, 'Varied MR appearance of
autism: fifty-three pediatric patients having the full autistic syndrome',
Magn Reson Imaging 1990;8(6):811-6
O'Carroll RE, Masterton G. Dougnall N. Ebmeier KP, 1995, 'The
neuropsychiatric sequelae of mercury poisoning: The Mad Hatter's disease
revisited', British Journal of Psychiatry 167(1):95-98 (1995)
O'Kusky JR, Boyes BE, McGeer EG, 'Methylmercury-induced movement and
postural disorders in developing rat: regional analysis of brain
catecholamines and indoleamines', Brain Research 1988 Jan
26;439(1-2):138-146
O'Neill JL, Through the Eyes of Aliens, Jessica Kingsley Publishers
Ltd., 1999
O'Neill M, Jones RSP, 'Sensory-Perceptual Abnormalities in Autism: A
Case For More Research?', Journal of Autism and Developmental Disorders,
1997, Vol. 27, No. 3, 283-293
O'Reilly BA and Waring, R, 'Enzyme and sulfur oxidation deficiencies
in autistic children with known food/chemical intolerances', Journal of
Orthomolecular Medicine 1993 4:198-200
Ono B, Sakamoto E, 'Saccharomyces cerevisiae strains sensitive to
inorganic mercury. I. Effect of tyrosene', Curr Genet 1985;10(3):179-185
Ono B, Sakamoto E, Yamaguchi K, 'Saccharomyces cerevisiae strains
sensitive to inorganic mercury. III. Tyrosine uptake', Curr Genet
1987;11(5):399-406
O'Reilly B, Waring R, 'Enzyme and Sulphur Oxidation Deficienceies in
Autistic Children with Known Food/Chemical Intolerences', pp. 249-252
Ornitz EM, 'Neurophysiologic Studies of Infantile Autism', Handbook of
Autism and Pervasive Developmental Disorders, John Wiley & Sons, Inc., 1987,
148-165
Otsuka H, 'Brain Metabolites in the Hippocampus-amygdala Region and
Cerebellum in Autism: an 1H-MR Spectroscopy Study', Neuroradiology 1999 Jul
Page T, Coleman M, 'Purine metabolism abnormalities in a
hyperuricosuric subclass of autism', Biochim Biophys Acta, 2000 Mar
17;1500(3):291-296
Page T, Yu A, Fontanesi J, Nyhan WL, 'Developmental disorder
associated with increased cellular nucleotidase activity', Proc. Natl. Acad.
Sci. USA, Vol. 94, October 1997, 11601-11606
Paul R, 'Natural History', Handbook of Autism and Pervasive
Developmental Disorders, John Wiley & Sons, Inc., 1987, 121-132
Pedersen MB, Hansen JC, Mulvad G, Pedersen HS, Gregersen M, Danscher
G, 'Mercury accumulations in brains from populations exposed to high and low
dietary levels of methyl mercury. Concentration, chemical form and
distribution of mercury in brain samples from autopsies', Int J Circumpolar
Health 1999 Apr;58(2): 96-107
Pediatrics 1999; 104:570-574, 'Thimerosal in vaccines: an interim
report to clinicians', Committee on Infectious Disease and Committee on
Environmental Health
Pendergrass JC, Haley BE, Vimy MJ, Winfield SA, Lorscheider FL,
'Mercury vapor inhalation inhibits binding of GTP to tubulin in rat brain:
similarity to a molecular lesion in Alzheimer diseased brain',
Neurotoxicology 1997;18(2):315-324
Perry E, Lee M, Court J, Perry R, 'Cholinergic Activities in Autism:
Nicotinic and Muscarinic Receptor Abnormalities in the Cerebral Cortex' ,
presentation to Cure Autism Now, 2000
Pfab R, Muckter H, Roider G, Zilker T, 'Clinical course of severe
poisoning with thiomersal', Clinical Toxicology 1996;34(4):453-460
Pierce PE, Jon F. Thompson, MPH William H. Likosky, MD; Laurance N.
Nickey, MD; William F. Barhtel; and Alan R. Hinman, MD, MPH, 'Alkyl Mercury
Poisoning in Humans', JAMA 1972 Vol 220, No11 1439-1442
Piikivi L, Hanninen H, Martelin T, et al, 'Psychological performance
and long-term exposure to mercury vapors', Scand. J. Work Environ. Health,
1984, 10:35-41
Piikivi L, Tolonen U, 'EEG findings in chlor-alkaliworkers subject to
low long term exposure to mercury vapor', Br. J. Ind. Med., 1989,
46(6):370-375
Pink Disease Support Group, www.users.bigpond.com/difarnsworth
Pirker C, Möslinger T, Wantke F, Götz, Jarisch R, 'Ethylmercuric
chloride: the responsible agent in thimerosal hypersensitivity', Contact
Dermatitis 1993:29:152-154
Piven J, Berthier M, Starkstein S, Nehme E, Pearlson G, Folstein S,
'Magnetic resonance imaging evidence for a defect of cerebral cortical
development in autism', American Journal of Psychiatry, June 1990, 147:6,
pp. 734-739
Piven J, Palmer P, 'Psychiatric disorder and the broad autism
phenotype: evidence from a family study of multiple-incidence autism
families', American Journal of Psychiatry, April 1999, Vol. 156, No. 4, pp.
557-563
Pless R, 'Summary of the Workshop on Thimerosal in Vaccines', Report
from the National Immunization Program, CDC, 1999
Plioplys A, 'Autism: Biomedical Perspectives', Presentation for the
Autism Society of America meeting, July 1989
Plioplys AV, Greaves A, Kazemi K, Silverman E, 'Immunoglobin
reactivity in autism and Rett's syndrome', Developmental Brain Dysfunction,
1994, 7:12-16
Plioplys AV, Greaves A, Kazemi K, Silverman E, 'Lymphocyte function in
autism and Rett Syndrome', Neuropsychobiology 1994;29(1) :12-6
Plioplys AV, Hemmens SE, Regan CM, 'Expression of a neural cell
adhesion molecule serum fragment is depressed in autism', J Neuropsychiatry
Clin Neurosci, 1990 Fall;2(4):413-7
Plotkin S, Orenstein W, Vaccines 1999
Prechtl HFR, 'Neurological Findings in Newborn Infants after Pre- and
Paranatal complications', Jonxis et al editors:Aspects of Prematurity and
Dysmaturity: a Nutrica symposium, Leiden:Stenfert Kroesse, 1968
Prizant BM, 'Brief Report: Communication, Language, Social, and
Emotional Development', Journal of Autism and Developmental Disorders, 1996,
Vol. 26, No. 2, 173-178
Purine Research Society, 'What We Learn About Metabolic Disease Will
Benefit Each and Every One of Us', Purine Research Society Website
Puschel G, Mentlein R, Heymann E, 'Isolation and characterization of
dipeptidyl peptidase IV from human placenta', Eur J Biochem 1982
Aug;126(2):359-65
Rajanna B and Hobson M, 'Influence of mercury on uptake of
[3H]dopamine and [3H]norepinephrine by rat brain synaptosomes', Toxicology
Letters 1985 Sep 27(1-3):7-14
Rajanna B, Hobson M, Harris l, Ware L, Chetty CS, 'Effects of cadmium
and mercury on Na(+)-K+, ATPase and uptake of 3H-dopamine in rat brain
synaptosomes', Arch Int Physiol Biochim 1990 Oct;98(5):291-296
Rice D, 'Lack of Effect of Methylmercury Exposure from Birth to
Adulthood on Information Processing Speed in the Monkey', September 1997,
Rice DC, 'Sensory and cognitive effects of developmental methylmercury
exposure in monkeys, and a comparison to effects in rodents', NeuroToxicol.,
1996, 17:139-154
Rice DC, Gilbert SG, 'Early chronic low-level methylmercury poisoning
in monkeys impairs spatial vision' Science 1982 May 14;216(4547):759-761
Richdale AL, 'Sleep problems in autism: prevalence, cause, and
intervention', Developmental Medicine and Child Neurology, 1999 Jan
41(1):60-6
Rimland B, 'Recovery from autism is possible', cited in Autism
Research Review International, 1994, Vol. 8, No. 2, p. 3
Rimland B, Baker SM, 'Brief Report: Alternative Approaches to the
Development of Effective Treatments for Autism', Journal of Autism and
Developmental Disorders, 1996, Vol. 26, No. 2, 237-241
Ritvo ER, Freeman BJ, Scheibel AB, Duong T, Robinson H, Guthrie D,
Ritvo A, 'Lower Purkinje cell counts in the cerebella of four autistic
subjects: intitial findings of the UCLA-NSAC Autopsy Research Report',
American Journal of Psychiatry, 1986;143:862-866
Ritvo ER, Freeman BJ, Creel D, Crandall AS, Pingree C, Barr R,
Realmuto G, 'Retinal Pathology in Autistic Children - A Possible Biological
Marker for Subtype?' (letter), Journal of the American Academy of Child
Psychiatry, January 1986, 25:137
Rodier PM, Ingram JL, Tisdale B, Croog VJ, 'Linking etiologies in
humans and animal models: studies of autism', Reproductive Toxicology, 1997,
Vol. 11, Nos. 2/3, pp. 417-422
Rodier, P.M., M. Aschner and P. R. Sager. 1984. Mitotic arrest in the
developing CNS after prenatal exposure to methyl mercury. Neurobehav.
Toxical. Teratol. 6:379-385.
Rogers SJ, 'Brief Report: Early Intervention in Autism', Journal of
Autism and Developmental Disorders, 1996, Vol. 26, No. 2, 243-246
Rogers T, Kalaydjieva, Hallmayer et al, 'Exclusion of Linkage to the
HLA Region in Ninety Multiplex Sibships with Autism', Journal of Autism and
Developmental Disorders, 1999 Jun;29(3):195-202
Rohyans J, Walson PD, Wood GA, MacDonald WA, 'Mercury toxicity
following merthiolate ear irrigations', The Journal of Pediatrics, 1984
Feb:311-313
Romani L, 'Immunity to Candida albicans: Th1, TH2 cells and beyond',
Curr Opin Microbiol 1999 Aug;2(4): 363-367
Rosenhall U, Johansson E, Gillberg C, 'Oculomotor findings in autistic
children', Journal of Laryngology and Otology, May 1988, Vol. 102, pp.
435-439
Rosenhall U, Nordin V, Sandstrom M, Ahlsen G, Gillberg C, 'Autism and
Hearing Loss', Journal of Autism and Developmental Disorders, Oct 1999 29(5)
349-358
Ross W. Donald, Gechman A, Sholiton M, Paul H, 'Alertness to
Neuropsychiatric Manifestations', Comprehensive Psychiatry, Vol. 18, No. 6,
pp. 595-598
Rossi AD, Ahlbom E, Ogren So, Nicotera P, Ceccatelli S, 'Prenatal
exposure to methylmercury alters locomotor activity of male but not female
rats', Exp Brain Res 1997 Dec;117(3):428-436
Roux S, Adrien J-L, Bruneau N, Malvy J, Barthelemy C, 'Behavior
Profiles within a population of 145 children with autism using the Behaviour
Summarized Evaluation scale: influence of developmental age', Autism, 1998
(Dec) 2(4) 235-266
Rumsey J, 'Conceptual problem-solving in highly verbal, nonretarded
autistic men', Journal of Autism and Dev. Disorders, 1985, Vol. 15, No. 1,
pp. 23-36
Rumsey JM, Hamburger SD, 'Neuropsychological findings in
high-functioning men with infantile autism, residual state', Journal of
Clinical and Experimental Neuropsychology, 1988, Vol. 10, No. 2, pp. 201-221
Russell J, Jarrold C, Hood B, 'Two Intact Executive Capacities in
Children with Autism: Implications for the Core Executive Dysfunctions in
the Disorder', Journal of Autism and Developmental Disorders, 1999, Vol. 29,
No. 2, 103-112
Rutter M, 'Autism research: prospects and priorities', Journal of
Autism and Developmental Disorders 1996 Apr;26(2):257-75
Rutter M, 'The development of infantile autism', Psychological
Medicine 1974 4:147-163
Ryu YH, Lee JD, Yoon PH, Kim DI, Lee HB, Shin YJ, 'Perfusion
impairments in infantile autism on technetium-99m ethyl cysteinate dimer
brain single-photon emission tomography: comparison with findings on
magnetic resonance imaging', Eur J Nucl Med 1999 Mar;26(3):253-259
Sager. P.R., Aschner, M., and Rodier, P.M. 'Persistent differential
alteration in developing cerebellar cortex of male and female mice after
methylmercury exposure', Dev. Brain Res. 12: 1-11 (1984)
Sakamoto E, Urata H, Ono B, 'Saccharomyces cerevisiae strains
sensitive to inorganic mercury. II. Effect of glucose', Curr Genet
1985;10(3):187-195
Sarafian TA, Bredesen DE, Verity MA, 'Cellular resistance to
methylmercury', Neurotoxicology, 1996 Spring Abstract, 17(1):27-36
Sayers LG, Brown GR, Michell RH, Michelangeli F, 'The effects of
thimerosal on calcium uptake and inositol 1,4,5-triosphate-induced calcium
release in cerebellar microsomes', Biochem J 1993 Feb 1;289 (Pt 3):883-887
Schuler AL, 'Thinking in Autism: Differences in Learning and
Development', Teaching Children with Autism, Kathleen Ann Quill, ed., 1995,
11-32
Sears LL, 'An MRI Study of the Basal Ganglia in Autism', Prog
Neuropsychopharmacol Biol Psychiatry, 1999 May
Shafer TJ, Atchison WD, 'Transmitter, ion channel and receptor
properties of pheochromocytoma (PC12) cells: a model for neurotoxicological
studies', Neurotoxicology 1991 Fall;12(3):473-492
Shattock P, Savery D, Autism as a Metabolic Disorder, Autism Research
Unit, University of Sunderland, Sunderland, UK, 1997
Shenker BJ, Datar S, Mansfield K, Shapiro IM, 'Induction of apoptosis
in human T-cells by organomercuric compounds: a flow dytometric analysis',
Toxicol Appl Pharmacol, April 1997, 143(2): 397-406
Shenker BJ, Guo TL, Shapiro IM, 'Low-level methylmercury exposure
causes human T-cells to undergo apoptosis: evidence of mitochondrial
dysfunction', Environmental Research, 1998 May; Section A 77(2):149-159
Shenker, B.J., Berthold, P., DeBolt, K., Rooney, C., Vitale, L.A., and
Shapiro, I.M. (1992). 'Immunotoxic effects of mercuric compounds on human
lymphocytes and monocytes. II. Alterations in cell viability',
Immunopharm. Immunotox. 14, 555-577.
Shenker, B.J., Berthold, P., Decker, S., Mayro, J.S., Rooney, C.,
Vitale, L.A., and Shapiro, I.M. (1993). 'Immunotoxic effects of mercuric
compounds on human lymphocytes and monocytes. III. Alterations in B-cell
function and viability', Immunopharm. Immunotox. 15, 87-112.
Siegel BV, Nuechterlein KH, Abel L, Wu JC, Buchsbaum MS, 'Glucose
metabolic correlates of continuous performance test performance in adults
with a history of infantile autism, schizophrenics, and controls',
Schizophrenia Research 1995 Sep 17(1):85-94
Sigman M, Ungerer JA, Mundy P, Sherman T, 'Cognition in Autistic
Children', Handbook of Autism and Pervasive Developmental Disorders, John
Wiley & Sons, Inc., 1987, 103-130
Singh VK, 'Plasma increase of Interleuken-12 and Interferon-gamma.
Pathological significance in autism', J Neuroimmunology, 1996
May;66(1-2):143-5
Singh VK, Warren RP, Odell D, 'Immune response to brain myelin in
autistic children', July 1992
Singh V, Warren R, Odell J, Warren W, Cole P, 'Antibodies to myelin
basic protein in children with autistic behavior', Brain, Behavior and
Immunity, 1993 Mar;7(1):97-103
Singh VK et al, Biological Psychiatry 1997 41: 753-755
Singh VK, Fudenberg HH, Emerson D, Coleman M, 'Immunodiagnosis and
immunotheraphy in autistic children', Annals of the New York Academy of
Science, 540, 1988, 602-604
Singh VK, Journal of Neuroimmunology 1996 66: 143-145
Singh,VK et al, Brain, Behavior and Immunity 1993 7: 97-103
Smalley SL, Collins F, 'Brief Report: Genetic, Prenatal, and
Immunologic Factors', Journal of Autism and Developmental Disorders, 1996,
Vol. 26, No. 2, 195-198
Smith D., 'Mental Effects of Mercury Poisoning', Presentation before
the Section on Family Practice, Southern Medical Association, 71st Annual
Scientific Assembly, November 6-9, 1977
Snyder RD. 'The involuntary movements of chronic mercury poisoning',
Archives of Neurology 1972;26:379-3381
Sperry VW, 'Family and personal section: From the inside out - a view
of the world as seen by one with Asperger syndrome', Autism, 1998
Marc;2(1):81-86
Sternberg RJ, 'A Unified Theoretical Perspective on Autism', Handbook
of Autism and Pervasive Developmental Disorders, Cohen DJ, Donnellan AM,
Paul R, eds, 1987 by John Wiley & Sons, p.690-696
Stevenson RE, Schroer RJ, Skinner C, Fender D, Simensen RJ, 'Autism
and macrocephaly', Lancet, 1997, 349:1744-1745
Stores G, Wiggs L, 'Abnormal sleeping patterns associated with autism:
a brief review of research findings, assessment methods and treatment
strategies', Autism, 1998 Jun;2(2):157-170
Stubbs EG, 'Autistic children exhibit undetectable
hemagglutination-inhibition antibody titers despite previous rubella
vaccination', Journal of Autism and Childhood Schizophrenia, 6, 269-274,
1976
Sutton KG, McRory JE, Guthrie H, Murphy TH, Snutch TP, 'P/Q-type
calcium channels mediate the activity-dependent feedback of syntaxin-1A',
Nature 1999 Oct 21;401(6755):800-4
Szasz A, Barna B, Szupera Z, De Vixxcher G, Galbacx Z, Kirsch-Volders
M, Szente M, 'Chronic low-dose maternal exposure to methylmercury enhances
epileptogenicity in developing rats', Int J. Devl Neurosci, 1999,
17.7.733-742
Szatmari P, Bartolucci G, Bremner R, Bond S, Rich S, 'A follow-up
study of high-functioning autistic children', Journal of Autism and
Developmental Disorders, June 1989, Vol. 19, No. 2, pp. 213-225
Tan XX, Tang C, Castoldi AF, Manzo L, Costa LG, 'Effects of inorganic
and organic mercury on intracellular calcium levels in rat T lymphocytes',
Journal of Toxicology & Environmental Health, 1993 Feb;38(2):159-170
Teitelbaum P, Teitelbaum O, Nye J, Fryman J, Maurer RG, 'Movement
analysis in infancy may be useful for early diagnosis of autism', Proc.
Natl. Acad. Sci. USA, Vol. 95, November 1998, 13982-13987
The MAAP, Volume IV, 1996; Volume VI, 1996; Volume III, 1999; Volume
IV, 1997; Volume II, 1997; Volume I, 1997; Volume II, 1998; Volume IV, 1998,
MAAP Services, Inc., PO Box 524, Crown Point, IN 46308
Thrower EC, Duclohier H, Lea EJ, Molle G, Dawson AP, 'The inositol
1,4,5-trisphosphate-gated Ca2+ channel: effect of the protein thiol reagent
thimerosal in channel activity', Biochem J 1996 Aug 15;318 (Pt 1): 61-66
Tokuomi H. Uchino M. Imamura S. Yamanaga H. Nakanishi R. Ideta T,
'Minamata disease (organic mercury poisoning): Neuroradiologic and
electrophysiologic studies', Neurology 1982;32:1369-1375)
Tonge BJ, Brereton AV, Gray KM, Einfeld SL, 'Behavioural and emotional
disturbance in high-functioning autism and Asperger's syndrome', Autism,
1999 Jun;3(2):117-130
Trottier G, Srivastava L, Walker CD, 'Etiology of Infantile Autism: a
review of recent advances in genetic & neurobiological research', Journal of
Psychiatry & Neuroscience, 1999 March 24(2):103-115
Tsai LY, 'Brief Report: Comorbid Psychiatric Dosorders of Autistic
Disorder', Journal of Autism and Developmental Disorders, April 1996
26(2)159-164
Tuunanen J, Halonen T, Pitkanen A, 'Decrease in
somatostatin-immunoreactive neurons in the rat amygdaloid complex in a
kindling model of temporal lobe epilepsy', Eiplepsy Res, 1997, 26.315-327
Tuunanen J, Halonen T, Pitkanen A, 'Status epilepticus causes
selective regional damage and loss of GABAergic neurons in the rat
amygdaloid complex,' Eur J Neurosci, 1996, 8:2711-2725
Tuunanen J, Lukasiak K, Halonen T, Pitkanen A, 'Status
epilepticus-induced neuronal damage in the rat amygdaloid complex:
distribution, time-course and mechanisms', Neurosci, 1999, 94.2.473-495
Uchida T, Naito S, Kato H, Hatano I, Harashima A, Terada Y, Ohkawa T,
Chino F, & Eto K, 'Thimerosal induces toxic reaction in non-sensitized
animals', International Archives of Allergy & Immunology, 1994
104(3):296-301
Vahter M, Mottet NK, Friberg L, Lind B, Shen DD, Burbacher T,
'Speciation of mercury in the primate blood and brain following long-term
exposure to methyl mercury', Toxicol Appl Pharmacol, 1994 Feb;124(2):221-229
Volterra A, Trotti D, Cassutti P, Tromba C, Salvaggio A, Melcangi RC,
Racagni G, 'High sensitivity of glutamate uptake to extracellular free
arachidonic acid levels in rat cortical synaptosomes and astrocytes',
Journal of Neurochemistry 1992 Aug 59(2):600-606
Volterra A, Trotti D, Cassutti P, Tromba C, Salvaggio A, Melcangi RC,
Racagni G, 'High sensitivity of glutamate uptake to extracellular free
arachidonic acid levels in rat cortical synaptosomes and astrocytes', J
Neurochem 1992 Aug;59(2):600-606
Von Burg R, Rustam H, 'Conduction Velocities in Methylmercury Poisoned
Patients', Bulletin of Environmental Contamination & Toxicology, 1974,
12(1):81-85
Von Burg R, Rustam H, 'Electrophysiological Investigations of
Methylmercury Intoxication in Humans. Evaluation of Peripheral Nerve by
Conduction Velocity and Electromyography', Electroencephalography and
Clinical Neurophysiology, 1974, 37:381-392
Vostanis P, Smith B, Corbett J, Sungum-Paliwal R, Edwards A, Gingell
K, Golding R, Moore A, Williams J, 'Parental concerns of early development
in children with autism and related disorders', Autism, September 1998, Vol.
2, No. 3, 229-242
Vroom FQ, Greer M, 'Mercury Vapour Intoxication', Brain (1972) 95,
305-318
Wakefield AJ, Murch SH, Anthony A, Linnell J, Casson DM, Malik M,
Berelowitz M, Chillon AP, Thomson MA, Harvey P, Valentine A, Davies SE,
Walker-Smith JA, 'Ileal-lymphoid-nodular hyperplasia, non-specific colitis,
and pervasive developmental disorder in children', The LANCET, February 28,
1998, Vol. 351, 637-641
Warfvinge K, Hua J, Logdberg B, 'Mercury distribution in cortical
areas and fiber systems of the neonatal and maternal cerebrum after exposure
of pregnant squirrel monkeys to mercury vapor', Environ Res 1994
Nov;67(2):196-208
Warkany J, Hubbard DH, 'Acrodynia and Mercury', J Pediatrics 1953
42;365-386
Warren RP, Margaretten NC, Foster A, 'Reduced Natural Killer Cell
Activity in Autism', Journal of the American Academy of Child and Adolescent
Psychiatry, 1987, Vol. 26, No. 3, pp. 333-335
Warren RP, Margaretten NC, Pace NC, Foster A, 'Immune Abnormalities in
Patients with Autism', Journal of Autism and Developmental Disorders, 1986,
Vol. 16, No. 2, pp. 189-197
Warren RP, Odell JD, Warren WL, Burger RA, Maciulis A, Daniels WW,
Torres AR, 'Strong association of the third hypervariable region of HLA-DRß1
with autism', Journal of Neuroimmunology 67 (1996) 97-102
Warren RP, Yonk LJ, Burger RA, Cole P, Odell JD, Warren WL, White E,
Singh VK, 'Deficiency of Suppressor-inducer (CD4+CD45RA+) T Cells in
Autism', Immunological Investigations, 1990 Jun 19(3):245-251
Watanabe C, Kasanuma Y, Dejima Y, Satoh H, 'The effect of prenatal
nethylmercury exposure on the GSH level and lipid peroxidation in the fetal
brain and placenta of mice', Tohoku J Exp Med 1999 Feb;187(2):121-126
Watzl B, Abrahamse SL, Treptow-van Lishaut S, Neudecker C, Hansch GM,
Rechkemmer G, Pool-Zobel BL, 'Enhancement of ovalbumin-induced antibody
production and mucosal mast cell response by mercury', Food Chem Toxicol
1999 Jun;37(6):627-37
Wecker L, Miller SB, Cochran SR, Dugger DL, Johnson WD, 'Trace Element
Concentrations in Hair From Autistic Children', J. ment Defic. Res. (1985)
29, 15-22
Weitzman A, Weisman R, Szekely GA, Wijsenbeek H, Livni E, 'Abnormal
immune response to brain tissue antigen in the syndrome of autism', Am J
Psychiatry 1982 Nov;139(11):1462-5
Whiteley P, Rogers J, Shattock P, 'Clinical features associated with
autism: observations of symptoms outside the diagnostic boundaries of
autistic spectrum disorders', Autism, December 1998, Vol. 2, No. 4, 415-422
Wild GC, Benzel EC, Essentials of Neurochemistry, Jones and Bartlett
Publishers, Inc., 1994
Williams D, Autism - An Inside-Out Approach, 1996, Jessica Kingsley
Publishers Ltd, London
Wing L, Attwood A, 'Syndromes of Autism and Atypical Development',
Handbook of Autism and Pervasive Developmental Disorders, John Wiley & Sons,
Inc., 1987, 3-19
Wing, Lorna (1996) 'Autism Spectrum Disorder', British Medical Journal
312: 327-328
Wu J, Takeo T, Kamimura N, Wada J, Suga S, Hoshina Y, Wakui M,
'Thimerosal modulates the agonist-specific cytosolic Ca2+ oscillatory
patterns in single pancreatic acinar cells of mouse', FEBS Lett 1996 Jul
22;390(2):149-152
Yamagata T, 'FRAXE mental retardation', Nippon Rinsho 1990
Apr;57(4):955-9
Yard BA, Lorentz CP, Herr D, and Van Der Woude F, 'Sulfation-dependent
down-regulation of interferon-gamma-induced Major Histocompatibility Complex
I and II Intercellular Adhesion Molecule-1 expression on tubular and
endothelial cells by glycosaminoglycans', Transplantation Vol.66(9),
November 15, 1998, pp. 1244-1250
Yazbak FE, 'Autism '99, a national emergency',
http://www.garynull.com/documents/autism_99.htm (Internet publication) 1999
Yeates KO & Mortensen ME, 'Acute and chronic neuropsychological
consequences of mercury vapor poisoning in two early adolescents', Journal
of Clinical Exp Neuropsychology, 1994 16(2):209-222
Yip RK, Riley DA, 'Effects of methylmercury on the motor and sensory
and innervation of the rat extensor digitorum longus muscle', Environ Res
1987 Jun;43(1):85-96.
Yuan Y, and Atchison WD, 'Comparative effects of methylmercury on
parallel-fiber and climbing fiber responses of rat cerebellar slices',
Journal of Pharmacology and Experimental Therapy 1999 Mar;288(3):1015-1025.
Zimmerman A, Brashear R, Frye V, Potter N, 'Anticerebellar Antibodies
in Autism', pp. 275-276
Zimmerman A, Frye VH, Potter NT, 'Immunological aspects of autism',
International Journal of Pediatrics, 8, 1993, 199-204
Zimmerman AW, Gonfardin B, Myers SM, Neuropharmacological therapy in
autism, Autism: Clinical and Research Issues, ed. Pasquale Accardo, et al.,
Timonium, MD: York Press, 1996
Measles (or MMR)
Vitamin A Improves Measles Complication Rates:
· Clinical Infectious Diseases (September 1994), p. 493.
· Oomen, APC. "Clinical experience of hypovitamine A." Fed Proc
1958; 17:111-124.
· Wilson, D., et al. "Infection and nutritional status. III.
The effect of measles on nitrogen metabolism in children." American Journal
of Clinical Nutrition 1961; 9:154-58.
· Sommer, A., et al. "Increased risk of respiratory disease and
diarrhea in children with pre-existing mild vitamin A deficiency." American
Journal of Clinical Nutrition 1984; 40:1090-95.
· Sommer, A., et al. "Impact of vitamin A supplementation on
childhood mortality: a randomized clinical trial." Lancet 1986; 1:1169-73.
· Barclay, A.J.G., et al. "Vitamin A supplements and mortality
related to measles: a randomised clinical trial." British Medical Journal
(January 31, 1987), pp. 294-96.
· Keusch, G.T. "Vitamin A supplements-too good to be true." New
England Journal of Medicine (October 4, 1990), p. 986.
· Frieden, T.R., et al. "Vitamin A levels and severity of
measles: New York City." Am J Dis Child 1992; 146:182-86.
· Pediatric Nursing (September/October 1996).
Fever Reducers (aspirin) Prolong Measles Complication Rates:
· Witsenburg, B.C. "Measles mortality and therapy," pp. 26-27.
From an abstract of a 1967-1968 measles epidemic study conducted in Ghana.
· Ahmady, A.S., et al. "The adverse effects of antipyretics in
measles." Indian Pediatrics (January 1981), pp. 49-52.
The Measles (and MMR) Vaccine and Neurological Disorders
(Including Central Nervous System Damage, subacute sclerosing
panencephalitis [brain disease], and Guillain-Barre' syndrome [paralysis]):
· Schneck, S.A. "Vaccination with measles and central nervous
system disease." Neurology 1968; 18 (Part 2):79-82.
· Jabbour, J.T., et al. "Epidemiology of subacute sclerosing
panencephalitis (SSPE)." Journal of the American Medical Association 1972;
220:959-62.
· Belgamwar, R.B., et al. "Measles, mumps, rubella vaccine
induced subacute sclerosing panencephalitis." Journal of the Indian Medical
Association 1997; 95(11):594.
· Landrigan, P.J., et al. "Neurological disorders following
live measles-virus vaccination." Journal of the American Medical Association
1973; 223 (13):1459-62.
· Miller, C.L. Lancet (September 17, 1983).
· Beale, A.J. "Measles vaccines." Proceedings of the Royal
Society of Medicine 1974; 67:1116-1119.
· Roden, A.T. "Fits following immunization." Proceedings of the
Royal Society of Medicine 1974; 67:24.
· Jagdis, F., et al. "Encephalitis after administration of live
measles vaccine." Journal of the Canadian Medical Association (April 19,
1975); 112(8):972-75.
· Hirayama, M. "Measles vaccines used in Japan." Reviews of
Infectious Diseases 1983; 5:495-503.
· Pollock, T.M., et al. "A 7-year survey of disorders
attributed to vaccination in Northwest Thames Region." Lancet 1983;
1:753-57.
· Jorch, G. et al. "Coincidence of virus encephalitis and
measles-mumps vaccination." Monatsschr Kinderheilkd 1984; 132(5):299-300.
· Martinon-Torres, F., et al. "Self-limited acute
encephalopathy related to measles component of viral triple vaccine." Rev
Neurol (May 1-15, 1999); 28(9):881-82.
· Grose, C., et al. "Guillain-Barré syndrome following
administration of live measles vaccine." American Journal of Medicine 1976;
60:441-43.
· Norrby, R. "Polyradiculitis in connection with vaccination
against morbilli, parotitis and rubella." Lakartidningen 1984; 81:1636-37.
· Morris, K., et al. "Guillain-Barré syndrome after measles,
mumps, and rubella vaccine." Lancet 1994; 343:60.
The Measles (and MMR) Vaccine and Serious Blood Disorders:
· Oski, F.A. and Naiman, J.L. "Effect of live measles vaccine
on the platelet count." New England Journal of Medicine 1966; 265:352-56.
· Bottiger, M., et al. "Swedish experience of two dose
vaccination programme aiming at eliminating measles, mumps, and rubella."
British Medical Journal 1987; 295:1264-67.
· Koch, J. et al. "Adverse events temporally associated with
immunizing agents-1987 report." Canada Diseases Weekly Report 1989;
15:151-58.
· Fescharek, R., et al. "Measles-mumps vaccination in the FRG:
an empirical analysis after 14 years of use. II. Tolerability and analysis
of spontaneously reported side effects." Vaccine 1990; 8:446-56.
· Nieminen, U., et al. "Acute thrombocytopenic purpura
following measles, mumps and rubella vaccination: A report on 23 patients."
Acta Paediatrica 1993; 82:267-70.
· 146. Farrington, P., et al. "A new method for active
surveillance of adverse events from diphtheria/tetanus/pertussis and
measles/mumps/rubella vaccines." Lancet 1995; 345: 567-69.
· Jonville-Bera, A.P., et al. "Thrombocytopenic purpura after
measles, mumps, and rubella vaccination: a retrospective survey by the
French Regional Pharmacovigilance Centres and Pasteur-Merieux Serums et
Vaccins." Pediatr Infect Dis J 1996; 15:44-48.
· Beeler, J. et al. "Thrombocytopenia after immunization with
measles vaccines: review of the Vaccine Adverse Events Reporting Systerm
(1990-1994)." Pediatr Infect Dis J 1996; 15:88-90.
The Measles (and MMR) Vaccine and Sensory Impairments
(Including Eye Disorders and Hearing Loss):
· Kazarian, E.L., et al. "Optic neuritis complicating measles,
mumps, and rubella vaccination." American Journal of Ophthalmology 1978;
86:544-47.
· Marshall, G.S., et al. "Diffuse retinopathy following
measles, mumps, and rubella vaccination." Pediatrics 1985; 76:989-991.
· Brodsky, L., et al. "Sensorineural hearing loss following
live measles virus vaccination." International Journal of Pediatric
Otorhinolaryngology 1985; 10:159-63.
· Nabe-Nielsen, J., et al. "Unilateral deafness as a
complication of the mumps, measles, and rubella vaccination." British
Medical Journal 1988; 297:489.
· Hulbert, T.V., et al. "Bilateral hearing loss after measles
and rubella vaccination in an adult." New England Journal of Medicine 1991;
325:134.
· Stewart, B.J.A., et al. "Reports of sensorineural deafness
after measles, mumps, and rubella immunisation." Archives of Diseases of
Childhood 1993; 69:153-54.
The Measles (and MMR) Vaccine and Immune System Damage
(Other Than Autism):
· Hirsch, R.L., et al. "Measles virus vaccination of measles
seropositive individuals suppresses lymphocyte proliferation and chemotactic
factor production." Clinical Immunology and Immunopathology 1981; 21:341-50.
· Nicholson, J.K.A., et al. "The effect of measles-rubella
vaccination on lymphocyte populations and subpopulations in HIV-infected and
healthy individuals." Journal of Acquired Immune Deficiency Syndromes 1992;
5:528-537.
The Measles (and MMR) Vaccine and Bowel Disease:
· Thompson, N.P., Wakefield, A.J, et al. "Is measles
vaccination a risk factor for inflammatory bowel disease?" Lancet 1995;
345:1071-1074.
· Barton, J.R., et al. "Incidence of inflammatory bowel disease
in Scottish children between 1968 and 1983: marginal fall in ulcerative
colitis; three-fold rise in Crohn's disease." Gut 1989; 30:618-622.
· Whelan, G. "Epidemiology of inflammatory bowel disease." Med
Clin N Am 1990; 74:1-12.
· Ekbom, A., et al. "The role of perinatal measles infection in
the aetiology of Crohn's disease: a population-based epidemiological study."
Lancet 1994; 334:508-510.
· Miyamoto, H., et al. "Detection of immunoreactive antigen
with monoclonal antibody to measles virus in tissue from patients with
Crohn's
disease." Journal of Gastroenterology 1995; 30:28-33.
· Wakefield, A.J., et al. "Evidence of persistent measles virus
infection in Crohn's disease." Journal of Medical Virology 1993; 39:345-53.
· Wakefield, A.J., et al. "Crohn's disease: pathogenesis and
persistent measles virus infection." Gastroenterology 1995; 108:911-916.
· Lewin, J., et al. "Confirmation of persistent measles virus
infection of intestinal tissue by immunogold electron microscopy." Gut 1995;
36:564-69.
The Measles (and MMR) Vaccine and Severe Allergic Reactions:
· Aukrust, L., et al. "Severe hypersensitivity or intolerance
reactions to measles vaccine in six children: clinical and immunological
studies." Allergy 1980; 35(7):581-87.
· McEwen, J. "Early-onset reaction after measles vaccination:
further Australian reports." Medical Journal of Australia 1983; 2:503-505.
· Koch, J., et al. "Adverse events temporally associated with
immunizing agents-1987 report." Canada Diseases Weekly Report 1989;
15:151-58.
· Kelso, J.M., et al. "Anaphylaxis to measles, mumps, and
rubella vaccine mediated by IgE to gelatin." J Allergy Clin Immunol 1993;
91:867-72.
· Sakaguchi, M., et al. "IgE antibody to gelatin in children
with immediate-type reactions to measles and mumps vaccines." J Allergy Clin
Immunol 1995; 96:563-65.
The Measles Vaccine and "Atypical" Measles:
· Cherry, J.D. "The 'new' epidemiology of measles and rubella."
Hospital Practice (July 1980), pp. 53-54.
· Fulginiti, V.A., et al. "Altered reactivity to measles virus;
atypical measles in children previously immunized with inactivated measles
virus vaccines." Journal of the American Medical Association 1967; 202:1075.
· Martin, D.B., et al. "Atypical measles in adolescents and
young adults." Annals of Internal Medicine 1979; 90:877.
· Gold, E. "Current progress in measles eradication in the
United States." Infect Med 1997; 14(4):297-300, 310.
· Nichols, E.M. "Atypical measles: a continuing problem."
American Journal of Public Health 1979; 69(2):160-62.
· Scott, T.F., et al. "Reactions to live-measles-virus vaccine
in children previously inoculated with killed-virus vaccine." New England
Journal of Medicine 1967; 277(5):248-251.
· Cherry, J.D., et al. "Atypical measles in children previously
immunized with attenuated measles virus vaccines." Pediatrics 1972; 50(5).
· St. Geme, J.W., et al. "Exaggerated natural measles following
attenuated virus immunization." Pediatrics 1976; 57:148-150.
· "Atypical measles syndrome." Lancet 1979, pp. 962-963.
The Measles Death Rate Tumbled Prior to the Measles Vaccine:
· Alderson, Michael. International Mortality Statistics
(Washington, DC: Facts on File, 1981), pp. 182-183.
The Measles Vaccine is Ineffective
(Outbreaks Often Occur Among Highly, or Fully, Vaccinated
Populations):
· FDA. "FDA workshop to review warnings, use instructions, and
precautionary information [on vaccines]." (Rockland, Maryland: FDA,
September 18, 1992), p. 27.
· Faich, G.A., et al. "Measles outbreak in Rhode Island."
Public Health Report 1981 May-June; 96(3):264-266.
· CDC. MMWR (February 1, 1985).
· CDC. MMWR (June 1984).
· CDC. MMWR (June 6, 1987).
· Gustafson, T. "Measles outbreak in a fully immunized
secondary school population." New England Journal of Medicine 1987;
316:771-74.
· Markowitz, L.E., et al. "Patterns of transmission in measles
outbreaks in the United States, 1985-1986." New England Journal of Medicine
1989; 320:75-81.
· Robertson, S.E., et al. "A million dollar measles outbreak:
epidemiology, risk factors, and a selective revaccination strategy." Public
Health Reports (January-February 1992), p. 24.
· Edmonson, M.B., et al. "Mild measles and secondary vaccine
failure during a sustained outbreak in a highly vaccinated population."
Journal of the American Medical Association 1990; 263:2467-71.
· Minnesota Department of Health. "Measles summary, 1987."
· CDC. "Measles." MMWR 1989; 38:329-330.
· CDC. "Measles-Quebec." MMWR 1989; 38:329-30.
· CDC. "Measles-United States, 1990. MMWR 1991; 40(2):369.
· CDC. "U.S. Childhood Immunization Update: Measles." (March
1997).
· CDC. "Measles-United States, 1999." MMWR 2000; 49(25):
557-560.
Natural Immunity is Superior:
· CDC. "Babies of vaccinated moms more susceptible to measles."
Pediatrics (November 1999).
· "Natural immunity to measles yields greater neutralizing
capacity than vaccination." Journal of Medical Virology 2000; 62:91-98.
The Measles Vaccine Alters the Epidemiology of the Disease (It Causes
Higher Rates of Measles in High-Risk Groups):
· Cherry, J.D. "The 'new' epidemiology of measles and rubella."
Hospital Practice (July 1980), p. 51.
· Macgregor, J.D., et al. "Epidemic measles in Shetland during
1977 and 1978." British Medical Journal 1981; 282(6262):434-436.
· Gold, E. "Current progress in measles eradication in the
United States." Infect Med 1997; 14(4):297-300, 310.
· CDC. "Measles-United States, 1999." MMWR 2000; 49(25):
557-560.
Authorities Experimented on Children with a Proven Deadly Measles
Vaccine:
· Sabin, A.B., et al. "Successful immunization of children with
and without maternal antibody by aerosolized measles vaccine. I. Different
results with undiluted human diploid cell and chick embryo fibroblast
vaccines." JAMA 1983; 249:2651-62.
· Sabin, A.B., et al. "Successful immunization of children with
and without maternal antibody by aerosolized measles vaccine. II. Vaccine
comparisons and evidence for multiple antibody response. JAMA 1984;
251:2363-71.
· Whittle, H.C., et al. "Immunisation of 4-6 month old Gambian
infants with Edmonston-Zagreb measles vaccine." Lancet 1984; ii:834-37.
· Whittle, H., et al. "Trial of high-dose Edmonston-Zagreb
measles vaccine in The Gambia: antibody response and side-effects." Lancet
1988; ii:811-814.
· Aaby, P., et al. "Trial of high-dose Edmonston-Zagreb measles
vaccine in Guinea-Bissau: protective efficacy." Lancet 1988; i:809-811.
· Garenne, M., et al. "Child mortality after high-titre measles
vaccines: prospective study in Senegal." Lancet 1991; 338:903-907.
· Whittle, H.C. "Effect of dose and strain of vaccine on
success of measles vaccination of infants aged 4-5 months." Lancet 1988;
i:963-66.
· Khanum, S., et al. "Comparison of Edmonston-Zagreb and
Schwartz strains of measles vaccine given by aerosol or subcutaneous
injection." Lancet 1987; i:150-53.
· Tidjani, O., et al. "Serological effects of Edmonston-Zagreb,
Schwartz, and AIK-C measles vaccine strains given at ages 4-5 or 8-10
months." Lancet 1989; ii:1357-60.
· Markowitz, L.E., et al. "Immunization of six-month-old
infants with different doses of Edmonston-Zagreb and Schwartz measles
vaccines." New England Journal of Medicine 1990; 332:580-87.
· Awadu, K.O. Outrage! How Babies Were Used as Guinea Pigs in
an L.A. County Vaccine Experiment. (Long Beach, CA: Conscious Rastra Press,
1996).
Tratto da: http://thinktwice.com/s_mmr.htm
Autism - 10
Altra Bilbiografia:
Allerdist H, "Complicazioni neurologiche a seguito di vaccinazioni di
morbillo", Dev Biol Stand, 1979; 43:259-64
Antony SJ, Fleming DF, Bradley TK, "Encefalopatia disseminata
(sindrome Brown-Sequard) post vaccino influenzale", J Natl Med Assoc., sett.
1995; 87(9):705-8
Askanas A, "Encefalite post-vaccinica ed infezione da enterovirus",
Pediatr Pol, feb. 1966
Auden GA, "Alterazioni nel comportamento intervenute a seguito di
encefalite in bambini", The Lancet 28 ott. 1922, p.901- 904
Backman Z, "Correlazione tra disabilità mentali, manifestazioni del
comportamento e tossicità ed allergia cerebrale", The Digest of Chiropractic
Economics, maggio- giugno 1985, p18-19
Bakwin H, "Danno cerebrale e disutrbi del comportamento in bambini",
J. Pediatrics 34 (1949) 371-382
Barbor PR, Grant DB, "Encefalite a seguito di vaccinazione per il
morbillo", The Lancet, 5 luglio 1969; 2 (7610): 55-6
Baylet RJ, Camain R, "Encefalite post-vaccinica: uno studio
virologico", Bull Soc Med Afr Noire Lang Fr, 1966;11(1):83-92
Begg NT, Noah ND, "Vaccinazioni per morbillo parotite e rosolia ed
encefalite", British Med. Journal, 14 ott. 1989; 299 (6705): 978
Bender L, "Encefalopatie in bambini", Arch Pediatrics 60 (1943),
p75-87
Bitnun A, "Encefalite causata dal ceppo vaccinale del virus del
morbillo", Clin Infect Dis., ott. 1999; 29(4):855-61
È riportato il caso di una encefalite da virus del morbillo in un
bambino apparentemente sano di 21 mesi, a distanza di 8 mesi dalla
vaccinazione morbillo parotite rosolia.
Bond ED, Appel KE, "Il trattamento dei disturbi comportamentali
derivanti da encefalite", New York: The Commonwealth Fund, 1931
Bond ED, Partridge GE, "Disturbi comportamentali post-encefalitici in
ragazzi e loro gestione in un ospedale", Am. J. Psychiatry VI (1926/ 1927),
p25-80
Bond ED, Smith LH, "Disordini comportamentali post-encefalitici:
rassegna di 10 anni alla Franklin School", Am. J. Psychiatry, (1935), 92: 1,
p17-33
Braginskaia VP, Sokolova AF, Ladodo KS, "Encefalite post-vaccinica in
un bambino di 3 anni e 4 mesi", Vopr Okhr Materin Det., apr. 1968;
13(4):75-7
Brezin A, Lautier-Frau M, Hamedani M, "Perdita di visione ed
eosinofilia a seguito di vaccino antiepatite B", The Lancet 1993; 342: 563-4
Buchner H, Ferbert A, Hundgen R, "Polineurite craniale? Encefalite e
mielite del cervelletto a seguito di vaccinazione influenzale preventiva",
Nervenarzt., nov. 1988; 59(11):679-82
Buchwald G, Steben B, "Encefalite ed encefalopatia post-vaccinica",
Med Welt, 22 ott. 1971
Byers, Randolph K, Moll FC, "Encefalopatie a seguito della
vaccinazione profilattica di pertosse", Pediatrics 1:4 (1948), 439-457
Campbell AG, "Vaccinazione morbillo, parotite e rosolia ed
encefalite", Brit Med. J., 7 ott. 1989; 299(6704): 916
Cavanagh, Brett EM, Marshall WC, Wilson J, "Il possibile ruolo
adiuvante della pertosse bordetella e del vaccino della pertosse nel causare
una grave sindrome encefalopatica: presentazione di 3 casi clinici",
Neuropediatrics 12: 374-381 (1981)
Cho CT, "Panencefalite a seguito di vaccinazione per morbillo", JAMA,
28 maggio 1973; 224 (9): 1299
Cherry JD, Brunell PA, Golden GS, Karzon DT, "Rapporto su rassegna su
pertosse e vaccinazione da pertosse", Pediatrics 81:6 Part 11 (giugno 1988)
Supplement pp 936-984.
citazione: Per più di 25 anni è stato ben noto che il vaccino
della pertosse è un affidabile adiuvante per la produzione di encefalite
allergica sperimentale. Questa encefalomielite allergica sperimentale è
mediata da linfociti sensibilizzati piuttosto che da meccanismi di anticorpi
del sangue. Il vaccino della pertosse è stato anche usato come adiuvante per
ottenere le seguenti patologie autoimmuni sperimentali: tiroidite,
miocardite, glomerulonefrite, uveoretinite ed anemia emolitica.
Collomb H, Dumas M, Giordano C, "Encefalite post-vaccinica (da
vaccino della febbre gialla): uno studio neuroradiologico", Bull Soc Med Afr
Noire Lang Fr. 1966;11(3):587-90
Collomb H, Rey M, Dumas M, "Sindromi neuropsichiche durante
encefaliti post-vacciniche", Bull Soc Med Afr Noire Lang Fr., 1966; 11(3):
575-86
Coulter H, Barbara F, "A shot in the dark", New York: Harcourt Brace
Jovanovich, 1985, Ed,. Verlag 1991
Crowley S, al-Jawad ST, Kovar IZ, "Vaccinazione morbillo parotite
rosolia ed encefalite", Br. Med. J., 9 sett. 1989; 299 (6700): 660
Damasio AR, Maurer RG, "Un modello neurologico per l'autismo
infantile", Archives of Neurology, v.35, 1978, p. 777-86
DeLong GR, Bean SC, Brown FR, "Reversibile sindrome autistica
acquisita in encefalopatia acuta in bambini", Arch. Neurology 38 (1981),
191-194
Dietrech RB, Bradley WG, Zaragoza EJ, Otto RJ, Taira RK, "Valutazione
con RM della modalità di mielinizzazione in infanti normali e ritardati
nello sviluppo", AJR 150 (aprile 1988), 889-896
Dietzsch HJ, "Encefalite a seguito della prima vaccinazione di
varicella nonostante pretrattamento con antigeni di vaccino", Kinderarztl
Prax., sett. 1966; 34(9):425-8
Dodson WE, "Encefalopatie metaboliche nella patofisiologia
neurologica", in: Eliason SG, Hardin WB, "Neurological pathophysiology", Ed.
1978, New York, Oxford
Dzagurov SG, Gurvich EB, Ozeretskovskii NA, "Risultati di uno studio
della patogenesi dell'encefalite post-vaccinica: 39 casi", Vopr Virusol,
luglio- agosto 1981; (4): 398-404
Ehrengut W, "Vaccinazioni di varicella con encefalite infantile
post-vaccinica", JAMA, 27 agosto 1973; 225 (9):1123
Ehrengut W. "Diabete mellito da encefalite post-vaccinica", Dtsch Med
Wochenschr., 15 maggio 1970; 95(20):1135
"Encefalite virale fatale a seguito di inoculazione di vaccino della
febbre gialla ceppo 17D. Rapporto di un caso di un bambino di 3 anni",
JAMA, 7 nov. 1966; 198(6):671-2
Fejerman N, "Encefalite post-vaccinica", Arch Argent Pediatr, ott.-
dic. 1964
Fejn DB, Skoff, mirsky AF, "Riscontri clinici di disfunzioni del
cervelletto in bambini autistici", J. Autism 11:3 (1981), 303-315
Froissart M, Mizon JP, Leroux JL, "Acuta meningoencefalite
immediatamente dopo una vaccinazione influenzale", Lille Med., ott. 1978;
23(8):548-51
Fujinami RS, Oldstone MB, "Omologia di amino acidi tra il sito
encefalitogenico delle proteine di base della mielina e il virus. Meccanismo
per l'autoimmunità", Science 1985, 230: 1043-45
Garcia-Monco JC, Coleman JL, Benach JL, "Anticorpi alla proteina di
base della mielina nel morbo di Lyme", J. of Inf. Dis. 1988; 158: 667-668
Gillberg C, "Sono l'autismo e l'anoressia nervosa correlati?", B. J.
Psychiatry 143 (april 1983), 428 (a)
Gillberg C, "Epilessia manifestatasi come autismo infantile? Due casi
clinici", Neuropediatrics 14 (1983), 206-212
Globus JH, Kohn JL, "Encefalopatia a seguito di vaccinazione di
pertosse", J. Amer. Med. Assoc. 141:8 (1949), 507-509
Goodwin, Cowan MA, "Malassorbimento e disfunzione cerebrale: uno
studio su bambini autistici", J. Autism 1 (1971), 48-62
Greenebaum JV, Leichentritt B, Rosenthal FM, "Effetti di encefaliti
insorte durante l'infanzia su comportamento e personalità: uno studio di
50 casi", Ohio Stata M. J., (1945) 4, 1018-1021
Gross WL, "Sindrome da meningoencefalite a seguito della vaccinazione
influenzale", J. Neurol., 14 feb. 1978; 217(3):219-22
Gurvich EB, "Isolazione del virus vaccinia da bambini con encefalite
post-vaccinica a vari intervalli dopo la vaccinazione", Acta Virol., gen.
1975; 19(1):92
Gurvich EB, "Virus vaccinia in encefalite post-vaccinica", Acta
Virol., marzo 1983; 27(2):154-9
Vengono descritti 84 casi di bambini con complicazioni neurologiche a
seguito di vaccinazione di varicella.
Harold E, Buttram MD, "Vaccino MPR (morbillo parotite rosolia) come
potenziale causa di encefalite (infiammazione del cervello) in bambini",
Townsend Letters, dic. 1997
Harper J, Williams S, "Stress ambientali precoci ed autismo
infantile", M. J. Australia, 9 marzo 1974, 341-346
Hemachudha T, Griffin DE, Giffels JJ, Johnson RT, Moser AB, Phanuphak
P, "Proteine di base della mielina come encefalitogeno in encefalomieliti e
polineuriti a seguito di vaccinazioni antirabbiche", New England J. Med.
316:7 (1987), 369-374
Herroelen L, de Keyser J, Ebinger G, "Demielinizzazione del sistema
nervoso centrale a seguito di immunizzazione con vaccino antiepatite B",
Lancet 1991; 338: 1174-75
Hetzler BE, Griffin JL, "Autismo infantile e lobo temporale del
cervello", J. Autism 11:3 (1981), 317-330
Hill TR, "Il problema dei disturbi di comportamento in bambini ed
epidemie di encefaliti croniche", J. Neurology and Psychopathology 9:33
(1928), 1-10
Hirtz DG, Nelson KB, Ellenberg JH, "Epilessia a seguito di
vaccinazioni infantili", J. Pediatrics 102:1, gen. 1983, 14-18
Horn W, "Encefalite a seguito di vaccino di varicella", Z Arztl
Fortbild (Jena), 15 nov. 1965; 59 (22): 1204-6
Iwasa S, Setsuji I, Akama K, "Rigonfiamento del cervello causato dal
vaccino di pertosse su topi", Japan. J. Med. Sci. Biol. 38 (1985) 53-65
Jacob J, Mannino F, "Aumento di pressione intracraniale a seguito di
vaccinazioni di difteria, tetano e pertosse", A. J. Dis. Children 133 (feb.
1979), p217-218
Jagdis F, Langston C, Gurwith M, "Encefalite a seguito di
somministrazione di vaccino di morbillo", Can Med Assoc J., 19 aprile 1975;
112 (8):972-5
Jennings AD, "Analisi del virus della febbre gialla isolato da un caso
fatale di encefalite umana associata a vaccino", J Infect Dis., marzo 1994;
169 (3):512-8
Jorch G, Kleine M, Erwig H, "Coincidenza di encefalite da virus e
vaccinazione morbillo parotite rosolia", Monatsschr Kinderheilkd., maggio
1984;132(5):299-300
Kahn E, Louis H, "Organic Driveness: a brainstem syndrome and an
experience", New England J. Med. 210: 14 (5 apr. 1934), 748-756
Kandt RS, "Esame neurologico di bambini con disabilità mentali",
Pediatric Clinics of North America 31:2 (aprile 1984), 297-315
Kaplanski G, Retornaz F, Durand J, Soubeyrand J, "Demielinizzazione
del sistema nervoso centrale a seguito di vaccinazione antiepatite B e
aplotipo HLA", J. Neurol Neurosurg Psychiatry, 1995; 58: 758-59
Kennedy RLJ, "La prognosi di sequelae di encefaliti epidemiche in
bambini", A.J. Dis. Children, 28 (1924) p158-172
Kim TM, "Encefalite da virus vaccinale del morbillo in ragazza di 9
anni: studi ultrastrutturali, immunoistochimici e di ibridazione in-situ",
Mod Pathol., maggio 1992; 5 (3):348-52
Klingmuller G, "Vaccinazioni di varicella ed encefalite
post-vaccinica", Med Welt., 17 luglio 1965; 29:1653-4
Komoto J, Otsuki S, "Autismo infantile e distrofia muscolare di
Duchenne", J. Autism, 14:2 (1984), 191- 195
Kreiner R, "Encefalite a seguito di vaccino antirabbica", Psychiatr
Neurol Med Psychol (Leipz), sett. 1971; 23 (9):532-6
Kulenkampff M, Schwartzman JS, Wilson J, "Complicazioni neurologiche
del vaccino di pertosse", Arch. Disease in Childhood 49:1 (gen. 1974), 46-49
Label LS, Batts DH, "Mielite trasversa causata da vaccino contenente
embrione di papera", Neurol.; 1982; 34: 426-36
Labauge R, "Encefalite post-vaccinica in adulto: un caso con rapporto
clinico- anatomico", Rev Neurol (Paris). 1979;135(11):803-13
È riportato il caso di un uomo di 27 anni che presentò 10 giorni dopo
una serie di vaccinazioni (7 vaccini in 2 mesi) coscienza alterata, attacchi
epilettici, emiplegia destra, disfunzioni vegetative e stato meningeo.
Low NL, "Studi elettroencefalografici a seguito di vaccinazione della
pertosse", J. Pediatrics 47 (1955), 35-39
Louis JJ, "Un caso di encefalite dopo vaccino della febbre gialla del
ceppo 17 D", Pediatrie, ott.- nov. 1981; 36 (7):547-50
Lurie LA, Greenebaum JV, Leichentritt B, Rosenthal FM, "Studi a lungo
termine su bambini con comportamento post-encefalitico", A. J. Psychiatry
(1947) 104, 171-179
Mar ID, "Encefalite a seguito della vaccinazione di febbre gialla",
Ann Pediatr (Paris), 2 marzo 1967; 14(3):181-91
Maurer RG, Damasio AR, "Autismo infantile dal punto di vista della
neurologia", J. Autism, 12:2 (1982), 195, 566- 569
McCann BS, "Asimmetrie emisferiche e autismo infantile", J. Autism
11:4 (1981), 401-411
Meerbach W, "Encefalite a seguito di vaccinazione della varicella",
Schweiz Med Wochenschr., 11 sett. 1971; 101(36):1311-5
Melchior JC, "Spasmi infantili e vaccinzioni infantili di pertosse",
Arch. Dis. in Childhood 52 (1977), 3-10
Merritt HH, "Textbook of neurology", sixth Edition, Philadelphia: Lea
and Febiger, 1979
Miller DL, Ross R, Alderslade R, Bellmann MH, "Vaccinazioni di
pertosse e gravi acute patologie neurologiche nei bambini", British M. J.
282 (16 maggio 1981), 1595- 1599
Miller HG, Stanton JB, "Conseguenze neurologiche di vaccinazioni", Q.
J. Medicine 24: 89 (1954), 1-27
Mnukhin SS, Isaev DN, "Sulla natura biochimica di alcune forme
schizzoidi o di psicopatia autistica", J. Autism 5 (1975), 99-108
Murphy JV, Sarff KM, Marquardt KM, "Attacchi epilettici ericorrenti a
seguito di vaccinazione di difteria, tetano e pertosse", A. J. Dis. Children
138 (ott. 1984), 908-911
Naumova RP, "Encefalite insorta a seguito di vaccinazione senza
reazione locale della pelle", Vrach Delo, luglio 1979, (7):114-115
Nalin DR, "Vaccinazioni di morbillo, parotite e rosolia ed
encefaliti", Br. Med. J., 11 nov. 1989; 299 (6709):1219
Neal J, "Encephalitis: a clinical study", New York: Grune and
Stratton, 1942 & Neal J, "Tipi di encefaliti epidemiche: un confronto dei
casi visti al St. Louis nel 1933 e quelli visti a New York", Am. J. Public
Health (1933), 23, p1144-1154
Osvath P, "Livelli IgE di infanti con complicazioni a seguito del
vaccino della pertosse", Allergol Immunopathol (Madr), marzo-apr. 1979;
7(2): 111-4
I livelli IgE di 31 infanti che ebbero gravi complicazioni a seguito
di vaccinazione di pertosse sono stati determinati attraverso RIST. I
pazienti ebbero convulsioni, encefalite o sintomi di shock anafilattico. 29
su 31 avevano elevati livelli IgE. Il vaccino della pertosse è già noto
provocare alterati stati di produzione Ige in roditori di laboratorio.
Palmar I, "Encefalopatia a seguito di vaccinazione per la varicella",
Vojnosanit Pregl., maggio 1972; 29(5):242-4
Pollock TM, "Sicurezza del vaccino della pertosse", Lancet, 1 ott.
1983; 2(8353):795-6
L'incidenza di bambini con anafilassi o collasso entro 24 ore dalla
vaccinazione DPT è di 6 su 100.000. Vengono riportati 8 di questi casi.
Poser CM, "Encefalite post-vaccinica", Ann. Neurology 1983; 13: 341-2
Prensky AL, "Il tempo: una quarta dimensione per le encefalopatie",
New England J. Med. 310:23 (1984), 1527-1528
Quitkin F, Klein Df, "Due sindromi comportamentali in giovani
correlate a possibile danno cerebrale minimo", J. Psychiatryc Research 7
(1969), 131-142
Rafalowska J, "Caso di encefalite necroticans acuta nel corso di una
reazione post-vaccinica", Neuropatol Pol, ott.- dic. 1965
Ravkina LI, "Encefalopatia post-vaccinica", Zh Nevropatol Psikhiatr Im
S S Korsakova, 1973; 73 (2): 191-4
Ribera EF, Dutka AJ, "Polineuropatia associata con la somministrazione
del vaccino antiepatite B", N. Eng. J. Med., 1983, 309: 614-15
Rivers JM, Schwentker, "Encefalomielite accompagnata da distruzione di
mielite prodotta sperimentalmente in scimmie", J. Exp. Med., 1935; 61:
689-702
Romanov VA, Bereshkova RV, "Studi patomorfologici ed
immunofluorescenti del neotropismo da vaccino della varicella", Zh Mikrobiol
Epidemiol Immunobiol, giugno 1975; (6):66-72
Iniezione di vaccino della varicella nella circolazione di maialini di
Guinea era accompagnata da sviluppo nel sistema nervoso di disturbi
circolatori sub-clinici e di fenomeni distrofici infiammatori di carattere
reversibile. Usando un metodo di immunofluorescenza gli antigeni del virus
del vaccino è stato rivelato nei neuroni del cervello e del fluido spinale
degli animali. Notevoli processi emodinamici e processi distrofici
infiammatori furono rivelati nel sistema nervoso di un bambino che era morto
di encefalite post-vaccinica; antigeni al virus della varicella furono
trovati in varie parti del sistema nervoso.
Rosenberg G, "Meningoencefalite a seguito del vaccino influenzale",
New England J. Med. 283 (1970), 12091211
Saito H, "Encefalomielite disseminata acuta a seguito di vaccinazione
influenzale", Arch Neurol., sett. 1980; 37(9): 564-6
Un 12enne, precedentemente sano, mostrò i tipici segni di
encefalomielite disseminata acuta 4 giorni dopo la vaccinazione influenzale.
La tomografia computerizzata dimostrò un'area sub-corticale di bassa
intensità nell'emisfero cerebrale sinistro. Il fluido cerebrospinale
conteneva elevati livelli di immunoglobuline, specialmente IgG, ed un
rapporto anomalo della catena kappa:lambda. Test cutanei per ipersensibilità
alla proteina dell'uovo furono negativi, ma fu osservato un nuovo aumento di
immunoglobuline e proteine del fluido cerebrospinale entro 10 giorni dai
test cutanei.
Salwa S, "Encefalite a seguito di vaccinazioni di varicella", Wiad
Lek., 1 feb. 1973; 26(3):215-9
Satz P, Soper DL, Orsini DL, Henry RR, Zvi JC, "Mancinismo
nell'autismo", Psychiatric Annals 15: 7 (luglio 1985), 447-449
Schain RJ, Yannet H, "Autismo infantile: un'analisi di 50 casi e
considerazioni su alcuni rilevanti concetti neurologici", J. Pediatrics 57:
4 (1960), 560-567
serafetinides EA, "Epilessia, dominanza cerebrale e comportamento",
in: M. Girgis & L.G. Kiloh ed., Limbic epilepsy and the dyscontrol syndrome.
Amsterdam: Elsevier/ North Holland Biomedical Press, 1980
Schmutzhard E, Pohl P, Stanek G, "Anticorpi Borrelia Burgdorferi in
pazienti con forma ad intermittenza di sclerosi multipla cronica
progressiva", J. Neurol Neurosurg Psychiatry, 1988; 5: 1215-1218
Schoub BD, "Encefalite in un ragazzo di 13 anni a seguito di vaccino
di febbre gialla del ceppo 17D", J. Infect., luglio 1990; 21(1):105-6
Schwebke D, "Osservazioni cliniche e di EEG in encefailte
post-vaccinica con risultato fatale", Kinderarztl Prax., luglio 1974;
42(7):307-12
Sen Gupta PN, "Encefalite post-vaccinica: rapporto di un caso", Indian
J Pediatr., dic. 1975; 42(335): 356-7
Shaw CM, Alvord FC, "Relazione mezzo di sospensione - antigene nella
produzione di encefalomielite sperimentale allergica in maialini della
Guinea", J. Exp. Med. 1935; 61: 689-702
Shaw FE, Graham DJ, Guess HA, "Controllo post-marketing degli eventi
avversi neurologici riportati a seguito di vaccino antiepatite B. Esperienza
dei primi 3 anni", Am J. Epidimiol, 1988, 127: 337:52
Stuart G, Krikorian KS, "Incidenti neuroparalitici del trattamento
antirabbica", Ann. Trop. Med. 1928; 23: 327-377
Swamy H, Anisya V, Nandi SS, Kaliaperumd VG, "Complicazioni
neurologiche dovute a vaccino antirabbica di tipo semplice. Aspetti clinici
e terapeutici", J. Assoc. Physicians India, 1991; 39: 667- 669
Steinman L, Sriram S, Adelman NE, Zamvil S, McDevitt HO, Urich H,
"Modello con murine per l'encefalopatia da vaccino della pertosse", Nature
299, 21 ott. 1982, 738-740
Stubbs EG, Crawford ML, Burger Dr, Vandenbark AA, "Depressione della
risposta linfocitaria in bambini autistici", J. Autism 7 (1977), 49- 55
Student M, Sohmer H, "Riscontri dalle risposte evocate da nervi
auditivi e cervelletto di lesioni organiche del cervello in bambini con
tratti autistici", J. Autism 8 (1978), 13- 20
Tanguay PE, Edwards RM, "Studi elettrofisici dell'autismo: il soffio
del crollo", J. Autism 12:2 (1982), 177-184
Tourbah A, Gout O, Liblau R, Cabanis EA, "Encefalite a seguito di
epatite B: encefalite disseminata ricorrente o sclerosi multipla?",
Neurology, 22 luglio 1999; 53 (2):396-40
Sono valutati 8 pazienti con infiammazione del sistema nervoso
centrale sviluppata entro 10 giorni settimane dalla vaccinazione
dell'epatite
B.
Trajkov N, "Encefalite a seguito di vaccino della varicella", God Zb
Med Fak Skopje., 1971; 17:469-75
Trevisani F, Gattinara GC, Caraceni P, "Mielite trasversa a seguito di
vaccini antiepatite B", J. Hepatol, 1993; 19: 317-18
Tjakradinata D, "Encefalite post-vaccinica", Paediatr Indones.,
nov.-dic. 1977; 17 (11-12):385-93
Vilesova IS, "Cambiamenti della proprietà del virus vaccinia isolato
in encefalite post-vaccinica", Vopr Virusol., luglio-agosto 1985;
30(4):477-82
Vich V, "Contributo al problema di edema cerebrale allergico, a
seguito di vaccinazione di varicella, che imita encefalite post-vaccinica",
Z Arztl Fortbild (Jena), 1 nov. 1968; 62 (21):1183-5
Wainsbren BA, Cashman N, Schell RF, Johnson R, "Anticorpi Borrelia
burgdorferi e sclerosi laterale amiotrofica", The Lancet, 1987; 2: 332-3
Wainsbren BA, "L'altra faccia della medaglia", Inf. Dis. News, 1992;
5:2
Walker AM, KnJick H, Thompson RS, "Eventi neurologici a seguito di
vaccinazione difteria tetano pertosse", Pediatrics 81:3 (marzo 1988), 345-
349
Warren WR, "Encefalopatia dovuta al vaccino influenzale", AMA Archives
Int. Med. 97 (1956), 803- 805
Watson JG, "Un bambino di 3 anni che ha sviluppato una reazione
encefalitica al vaccino MPR (morbillo, parotite, rosolia) all'età di 15
mesi", Int J Pediatr Otorhinolaryngol., giugno 1990; 19 (2):189-90
Westall FC, Root-Bernstein RS, "Una spiegazione della prevenzione e
della soppressione di encefalomieliti allergiche sperimentali", Mol. Immunol
1983; 2: 169-177
White F, "Vaccino del morbillo associato con encefalite in Canada",
Lancet, 17 sett. 1983; 2(8351): 683-4
Wiersbitzky S, "Encefalite, meningite serosa e parotite a seguito di
vaccinazione preventiva MPR?", Kinderarztl Prax., ott. 1992; 60(7):203-5
Wiersbitzky S, "Encefalite a seguito di contemporanea vaccinazione
DPT, polio trivalente orale (Sabin) ed influenzale HiB", Kinderarztl Prax.,
giugno 1993; 61(4-5):172-3
Wiersbitzky S, "Encefalite da vaccinazione a seguito di vaccino del
morbillo simile a disfunzioni ricorrenti cardiovascolari?", Kinderarztl
Prax., giugno 1991; 59(6):187-8
Wiersbitzky S, "Attacchi cerebrali e encefalite a seguito di vaccini
MPR, polio orale, influenzale HiB o DPT", Kinderarztl Prax., agosto 1993;
61(6):232-4
Woods CA, "Encefalopatia dovuta al vaccino influenzale", J. Pediatrics
65 (1964), 745- 748
Yates A, "Autismo: le evidenze di danno dell'emisfero sinistro",
Arizona Medicine 16 (1984), 395-397
Autism: A Unique Type of Mercury Poisoning Sallie, Bernard*, Albert
Enayati, B.S., Ch.E., M.S.M.E.**, Teresa Binstock, Heidi Roger, Lyn Redwood,
R.N., M.S.N., C.R.N.P., Woody McGinnis, M.D.
http://www.altcorp.com/autism.htm
So What's Not to Like About Andrew Wakefield ?
http://www.autism-spectrum.com/vaccine.htm
Secrets and lies: Is the astonishing rise in autism a medical mystery
or a pharmaceutical shame?
By Lesli Mitchell
Childhood jab linked to rise in cases of autism (Daily Express May 23,
2000) Ted Koren, D. C.
http://www.odyssee.net/~expodome/autism.htm#Top
Vaccines-Trigger for Autism?
http://www.odyssee.net/~expodome/trigger.htm#Top
Why Does The MMR Vaccine Need To Be Suspended ?
http://www.argonet.co.uk/users/jabs/mmrsuspend.html
Autism : Is there a vaccine connection? Part I. Vaccination after
delivery.------ F. Edward Yazbak, MD,
FAAP.
http://www.garynull.com/documents/autism99b.htm
Pt 2 http://www.garynull.com/documents/autism99b2.htm
Laura J. Ruede, MLS reply to "THE ABCs OF MMRs AND DTPs: IS THERE AN
ASSOCIATION BETWEEN VACCINATION AND AUTISM?" BY ERIC LONDON (A BIBLIOGRAPHIC
ESSAY rev. 5-17-99 ) 60 pages
http://lib.tcu.edu/www/staff/lruede/autvacc
IMMUNE RESPONSE TO BRAIN MYELIN IN AUTISTIC CHILDREN by Vijendra K.
Singh, Reed P. Warren, Dennis Odell Utah State University, July 1992
http://attila.stevens-tech.edu/spons_proj/pages/immune.html
Measles-Mumps-Rubella (MMR) Vaccine as a Potential Cause of
Encephalitis (Brain Inflammation) in Children by Harold E. Buttram, MD
Townsend Letters Dec. 1997
http://www.mercola.com/issue5.htm
The Autism Explosion by Dr Rimland (with graph showing rise in autism
since MMR vaccine)
http://autism.com/ari/editorials/explosion.html
AUTISM RESEARCH REVIEW INTERNATIONAL Vol. 12, No.1, 1998 EDITOR'S
NOTEBOOK Bernard Rimland. Ph.D. ----
Vaccinations: The Overlooked Factors
The Role of Vaccines in the Causation of Autism and Related
Disorders---Paul Shattock and Dawn Savery, Autism Research Unit, University
of Sunderland, Sunderland, UK.1997
IS AUTISM A G-ALPHA PROTEIN DEFECT REVERSIBLE WITH NATURAL VITAMIN A?
http://home.att.net/~pediatricaac/
Autism 99 A National Emergency
http://www.garynull.com/Documents/autism_99.htm
Dawbarns solicitors vaccine fact sheet also here: Society For The
Autistically Handicapped
http://www.rmplc.co.uk/eduweb/sites/autism/index.html
MMR Vaccinations and Interferon-Gamma possible sequelae: neurologic
and/or gastrointestinal by Teresa Binstock
http://www.jorsm.com/~binstock/mmr-immu.htm
VACCINATION-INDUCED NEUROPATHIES Infection, Autoimmunity, and Autism
by Teresa Binstock
http://www.jorsm.com/~binstock/vin.htm
Binstock, T. Hypothesis: Infection, antibiotics, vaccination-induced
neuropathies: Mechanisms of pathogenesis in some cases of autism, ADHD,
Tourette's, OCD, and other neurological disorders.Bit.listserv.autism
January 3 1997.
Complete articles at: http://www.whale.to/vaccines/autism23.html
Tratto da: http://www.mednat.org/vaccini/autism_ref.htm
--
dr. G. Paolo Vanoli - Giornalista pubblicista, Consulente in Scienza della
Nutrizione e Medicine Biologico Naturali
www.mednat.org/curriculum.htm